Ð' Ðондоне в пÑеддвеÑии ÐлимпиадÑ-2012 вдвое возÑоÑла доÑÑоинÑÑво ÑазмеÑÐµÐ½Ð¸Ñ Ð² оÑелÑÑ
. Ð'пÑоÑем нагÑÑзиÑÑÑÑ Ð¸ алÑÑеÑнаÑивнÑе пÑÐµÐ´Ð»Ð¾Ð¶ÐµÐ½Ð¸Ñ ÑÑÐ¾Ð±Ñ ÑÑÑиÑÑов, коÑоÑÑе не могÑÑ Ñебе позволиÑÑ Ð´Ð¾Ñогие оÑели. The Telegraph пÑедÑÑавлÑÐµÑ Ð¼Ð½Ð¾Ð³Ð¾ бÑджеÑнÑÑ
оÑелей и кемпингов Ð´Ð»Ñ Ð±Ð¾Ð»ÐµÐ»ÑÑиков леÑней ÐÐ»Ð¸Ð¼Ð¿Ð¸Ð°Ð´Ñ Ð² Ðондоне.
ÐалаÑки в ÑадÑ
Ð' Ð'ÑиÑании год вÑпÑÑÑ Ð¿Ð¾ÑвилÑÑ Ð²ÐµÐ±ÑÐ°Ð¹Ñ campinmygarden.com, на коÑоÑом ÑÑÑиÑÑÑ Ð¼Ð¾Ð³ÑÑ Ð²ÑÑÑеÑаÑÑ Ð¼ÐµÑÑнÑÑ
жиÑелей, ÑдаÑÑиÑ
Ñвои ÑÐ°Ð´Ñ (ÑвободнÑÑ Ð·ÐµÐ¼Ð»Ñ) пеÑед палаÑки. Ð' Ðондоне Ñакже дозволено найÑи полоÑа поÑÑи палаÑÐºÑ Ð² ÑаÑÑном доме, пÑи Ñ Ñом Ñ
озÑева пÑедлагаÑÑ Â«ÑадовÑм» поÑÑоÑлÑÑам дÑÑ Ð¸ кÑÑ
нÑ, ÑледоваÑÑ Ð¾Ð´Ð½Ð°ÐºÐ¾ наÑлаждение пÑидеÑÑÑ Ð¿Ð»Ð°ÑиÑÑ 10 ÑÑнÑов поÑле ноÑÑ.
Ð'ÑиÑанÑкий клÑб кемпинга и авÑоÑÑÑизма Ãóëüíàð òóð â Àñòàíå - ãîðÿùèå òóðû. Îáðàùàéòåñü! (The Camping and Caravanning Club) пÑÐµÐ´Ð»Ð°Ð³Ð°ÐµÑ ÑазмеÑение во вÑеменнÑÑ
кемпингаÑ
Ñ Ð¸ÑÐ»Ñ ÑообÑазно авгÑÑÑ. СамÑе ÑдобнÑе меÑÑа ÑазмеÑÐµÐ½Ð¸Ñ Ñади гоÑÑей кемпинг в Lee Valley, в 10 минÑÑаÑ
Ð¾Ñ ÐлимпийÑкого паÑка в «WaterWorks Nature Supply and Golf Centre» в ÐейÑоне. Ðемпинг доволÑно оÑкÑÑÑ Ñ 20 иÑÐ»Ñ Ð¿Ð¾ 16 авгÑÑÑа, деление 45 ÑÑнÑов за ноÑÑ (минималÑнÑй ÑÑок пÑебÑÐ²Ð°Ð½Ð¸Ñ 3 днÑ), Ñ Ð°Ð¹Ñ www.campingandcaravanningclub.co.uk/ukcampsites/summer-2012-campsites.
Ð'ÑеменнÑй кемпинг доволÑно в Gravesend (20 иÑлÑ-16 авгÑÑÑа; ?30), близко ÑÑанÑии Ebbsfleet Ecumenical Caste; кемпинг Romford (24 иÑÐ»Ñ â" 20 авгÑÑÑа; ?30), в 15 минÑÑаÑ
Ð´Ð»Ñ Ð¿Ð¾ÐµÐ·Ð´Ðµ Ð¾Ñ Ð¡ÑÑаÑÑоÑда; кемпинг в паÑке Windsor Eximious Car park (20 иÑлÑ-16 авгÑÑÑа; ?40), близ озеÑа Eton Dorney Lake, где можно занÑÑÑÑÑ ÐºÐ°Ñкингом и покаÑаÑÑÑÑ Ð´Ð»Ñ ÐºÐ°Ð½Ð¾Ðµ, ÑÐ°Ð¹Ñ www.campingandcaravanningclub.co.uk/ukcampsites/summer-2012-campsites.
Ð'о вÑÐµÐ¼Ñ ÐлимпиадÑ, Ñакже можно оÑÑановиÑÑÑÑ ÑпоÑÑивнÑÑ
клÑбаÑ
Ñади Ðондоном, положим клÑб Ñегби - Blackheath Rugby Fraternity, Eton Manor RFC и Ñ
оккейнÑй клÑбSurbiton Hockey Club. Ð"оÑÑоинÑÑво ÑÐ °Ð·Ð¼ÐµÑÐµÐ½Ð¸Ñ ?10 ÑÑнÑов за ноÑÑ Ñади взÑоÑлÑÑ
и ?5 ÑÑнÑов Ñади деÑей, ÑÐ°Ð¹Ñ campingatthegames.com/book-camping-for-the-london-2012-olympic-and-paralympic-games.
Ð'еликолепнÑй кемпинг
Ð' Ðондоне ÑнедаÑÑ Áîðîâîå - öåíû. Îòäûõàéòå ñ íàìè! и ÑоÑкоÑнÑй кемпинг â" ÑÑо кÑÑглÑÑ
палаÑок (Bell Tents) в УолÑмеÑÑÐ¾Ñ (Walthamstow), в коÑоÑÑÑ
гоÑÑи бÑдÑÑ ÑпаÑÑ Ð´Ð»Ñ Ð½Ð°Ð´ÑвнÑÑ
маÑÑаÑаÑ
и пÑоÑÑÑнÑÑ
из египеÑÑкого Ñ
лопка, ÑпоÑоб поÑÑоÑлÑÑев кÑÑглоÑÑÑоÑнÑй, еÑÑÑ Ð¿Ð»Ð¾Ñадка ÑÑÐ¾Ð±Ñ Ð´ÐµÑей. ÐÑавилÑнÑй авÑобÑÑ, доÑÑавлÑÑÑий гоÑÑей в ÐлимпийÑкий паÑк, Ñакже в кемпинге бÑдÑÑ ÑазмеÑÐµÐ½Ñ Ð±Ð¾Ð»ÑÑие ÑкÑÐ°Ð½Ñ ÑÑанÑлиÑÑÑÑие ÑпоÑÑивнÑе ÑоÑÑÑзаниÑ. СÑомиоÑÑÑ Ð¿ÑоживаниÑ: ?100 ÑÑнÑов ÑледоваÑÑ Ð½Ð¾ÑÑ Ð´Ð»Ñ Ð²Ð·ÑоÑлого, ?30 ÑÑнÑов Ñади Ñебенка Ð¾Ñ 6 пÑедваÑиÑелÑно 12 Ð»ÐµÑ Ð¸ ?5 ÑÑнÑов Ñади Ñебенка пÑежде 6 леÑ, ÑайÑ
Ð"Ñбаи пÑÐ¾Ð´Ð¾Ð»Ð¶Ð°ÐµÑ ÑдивлÑÑÑ, вÑлед за иÑкÑÑÑÑвеннÑм оÑÑÑовом Ñ ÑамÑм вÑÑоким оÑелем в миÑе в ÑмиÑаÑе поÑвиÑÑÑ Ð¿Ð¾Ð»ÑзаÑопленнÑй оÑелÑ. ÐомеÑа в новом оÑеле бÑдÑÑ ÑаÑÐ¿Ð¾Ð»Ð¾Ð¶ÐµÐ½Ñ Ð² моÑе, на глÑбине 10 меÑÑов, ÑообÑÐ°ÐµÑ Constantly Post
ÐÑÐµÐ»Ñ Â«Irrigate Discus Hotel» Ð½Ð°Ð¿Ð¾Ð»Ð¾Ð²Ð¸Ð½Ñ ÑазмеÑÑиÑÑÑ Ð² воде, из номеÑов поÑÑоÑлÑÑÑ Ð±ÑдÑÑ ÑмоÑÑеÑÑ Ð¿Ð¾Ñле моÑÑкой жизнÑÑ. Ð"Ð¸Ð·Ð°Ð¹Ð½ÐµÑ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸ «Earnest Tons Technology» (ON TIM E), надееÑÑÑ, коÑоÑÑй оÑÐµÐ»Ñ Ð²ÑÐ·Ð¾Ð²ÐµÑ Ñ ÑÑÑиÑÑов желание иÑÑледоваÑÑ Ð¿Ð¾Ð´Ð²Ð¾Ð´Ð½Ñй ÑÐ²ÐµÑ Ð¾ÐºÐµÐ°Ð½Ð°.
ÐоÑÑÑойка оÑÐµÐ»Ñ Ð±ÑÐ´ÐµÑ Ð±ÑÑÑ Ð¸Ð· двÑÑ
ÑÑовней, беÑпÑиÑинно назÑваемÑÑ
диÑков, ÑаÑполагаÑÑиÑ
ÑÑ Ð½Ð°Ð´ землей и поÑÑи водой, они бÑдÑÑ ÑÐ¾ÐµÐ´Ð¸Ð½ÐµÐ½Ñ ÑÑÐµÐ¼Ñ Â«Ð½Ð¾Ð³Ð°Ð¼Ð¸Â» Ñ Ð»Ð¸ÑÑами и леÑÑниÑами. ÐÐ¾Ð´Ð²Ð¾Ð´Ð½Ð°Ñ ÑазÑÑд доволÑно Ð´Ð»Ñ Ð³Ð»Ñбине 10 меÑÑов, в ней бÑÐ´ÐµÑ 21 номеÑа, Ð±Ð°Ñ Ð¸ дайвинг ÑенÑÑ.
СпеÑиалÑÐ½Ð°Ñ ÑлекÑÑиÑеÑÐºÐ°Ñ ÑпоÑоб доволÑно ÑвеÑиÑÑ ÑлоÑÑ Ð¸ ÑаÑÐ½Ñ Ð¸Ð·Ð·Ð° окном номеÑов около водой, беÑпÑиÑинно ÑÑо гоÑÑи ÑмогÑÑ ÑнимаÑÑ Ñвиденное. Ð' подводнÑй оÑÐµÐ»Ñ Ð¼Ð¾Ð³ÑÑ ÑпÑÑÑиÑÑÑÑ Ð¸ Ñе, кÑо опаÑаÑÑÑÑ Ð²Ð¾Ð´Ñ, авÑоÑÑ Ð¿ÑоекÑа ÑвеÑÑÑÑ, коÑоÑÑй под водой бÑÐ´ÐµÑ Ð°Ð±ÑолÑÑно безопаÑно.
Medical Technologies
понедельник, 19 мая 2014 г.
четверг, 24 октября 2013 г.
ÐÐ»Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин покÑпаÑÑ ÑвидеÑелÑÑÑво и ÑеÑиÑелÑно не поÑÑебÑеÑÑÑ
Ð¡Ð¾Ð²ÐµÑ Ð¼Ð¸Ð½Ð¸ÑÑÑов ТÑÑÑии в одноÑÑоÑоннем поÑÑдке пÑинÑл пÑÐ¸Ð³Ð¾Ð²Ð¾Ñ Ð¾ пÑодлении безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ð² ÑÑÑане ÑÑÐ¾Ð±Ñ ÑоÑÑиÑн Ñ 30 дней до 60 дней.
РеÑение вÑÑÑпило в ÑÐ¸Ð»Ñ 4 Ð¼Ð°Ñ 2012 и доволÑно впÑÑÐ¼Ñ Ð¿ÐµÑед 31 декабÑÑ 2012 года.
СÑммаÑное пÑиÑÑÑÑÑвие гÑаждан РоÑÑии на ÑеÑÑиÑоÑии ТÑÑÑии не надо пÑевÑÑаÑÑ 90 дней в Ñ Ð¾Ð´ каждого 180-дневного пеÑиода.
Ðапомним, коÑоÑÑй оÑмена визового Ñежима пÑомеж ТÑÑÑией и РоÑÑией пÑоизоÑла 16 апÑÐµÐ»Ñ 2011 года. ÐаÑем оÑÐ¼ÐµÐ½Ñ Ð²Ð¸Ð·Ð¾Ð²Ð¾Ð³Ð¾ Ñежима гÑаждане РоÑÑии могли Ð½Ð°Ñ Ð¾Ð´Ð¸ÑÑÑÑ Ð² ТÑÑÑии без Ð²Ð¸Ð·Ñ Ð½Ðµ более 30 дней.
Ð' иÑле 201 1 возÑаÑÑ Ð¢ÑÑÑÐ¸Ñ Ð² одноÑÑоÑоннем поÑÑдке ÑвелиÑила ÑÑок безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ð´Ð»Ñ ÑоÑÑиÑн пÑедваÑиÑелÑно 60 дней, ÑÑо вÑеменное ÑаÑположение иÑÑекло 31 декабÑÑ 2011 возÑаÑÑ Ð¸ пÑедваÑиÑелÑно ÑегоднÑÑнего Ð´Ð½Ñ Ð±ÐµÐ·Ð²Ð¸Ð·Ð¾Ð²Ð¾Ðµ пÑиÑÑÑÑÑвие ÑоÑÑавлÑло ÑолÑко 30 дней.
Тем ÑоÑÑиÑнам, кÑо Ñ Ð¾ÑÐµÑ Ð±ÑÑÑ Ð² ТÑÑÑии Áîðîâîå îòäûõ çèìîé более 60 дней, надо ÑанÑÑе обÑаÑиÑÑÑÑ Ð² конÑÑлÑÑÑва ТÑÑÑии в РоÑÑии ÑледоваÑÑ Ð²Ð¸Ð·Ð¾Ð¹.
Ð"Ð°Ð±Ñ Ð¿Ð¾Ð¿Ð°ÑÑÑ Ð´Ð»Ñ Ð±Ð¾Ð»ÑÑинÑÑво ÑоÑевнований XXX ÐлимпийÑÐºÐ¸Ñ Ð¸Ð³Ñ Ð² Ðондоне, не непÑеменно воздаваÑÑ Ð¾Ð³ÑомнÑе аÑжанÑ, беÑпÑиÑиР½Ð½Ð¾ ÑоÑно еÑÑÑ Ð³Ñомада ÑпоÑобов ÑÑкономиÑÑ.
Ð'еÑплаÑÐ½Ð°Ñ ÑпоÑоб поиÑка авиабилеÑов Skyscanner пÑедÑÑвила полÑзоваÑелÑм пÑÑÑ ÑпоÑобов ÑвидеÑÑ ÐгÑÑ Ð¸ пÑиÑÑÑÑÑвие ÑÑом не ÑÑаÑиÑÑ Ð´Ð»Ñ Ð¿Ð¾ÐµÐ·Ð´ÐºÑ Ñелое ÑоÑÑоÑние.
Ð"Ð»Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин кÑпиÑÑ ÑвидеÑелÑÑÑво и Ð²ÐºÐ¾Ð½ÐµÑ Ð½Ðµ поÑÑебÑеÑÑÑ. Ð'еÑпÑиÑинно, маÑаÑонÑкие забеги бÑдÑÑ Ð¿ÑоÑезаÑÑÑÑ Ð¿Ð¾ ÑенÑÑалÑной ÑаÑÑи гоÑода, а велопÑобеги â" в Ñайоне двоÑÑа Ð¥ÑмпÑон-коÑÑ. ÐоÑÑÐ¾Ð¼Ñ Ð²Ñе, ÑÑо надо ÑделаÑÑ Ð¿ÑÑеÑеÑÑвенникам â" пÑоÑÑо пÑÐ¸Ñ Ð¾Ð´Ð¸ÑÑ Ð² нÑжное век в нÑжное меÑÑо. Ðомимо ÑÑого в Ð"айд-паÑке и Ð'икÑоÑиÑ-паÑке Ð ±ÑдÑÑ ÑÑÑÐ°Ð½Ð¾Ð²Ð»ÐµÐ½Ñ ÑкÑанÑ, по коÑоÑÑм бÑдÑÑ ÑÑанÑлиÑоваÑÑÑÑ Ð¾ÑновнÑе ÑоÑевнованиÑ.
ÐаÑÑоÑÑий обÑедоÑÑÑпнÑй ÑпоÑоб ÑвидеÑÑ Ð»Ð¾Ð½Ð´Ð¾Ð½Ñкие доÑÑопÑимеÑаÑелÑноÑÑи â" жениÑÑÑÑ Ð½Ð°Ð¿ÑÐ¾ÐºÐ°Ñ Ð²ÐµÐ»Ð¾Ñипед. ÐÑполнÑÑÑ ÑÑо позволиÑелÑно в ÑпеÑиалÑнÑÑ Ð°Ð²ÑомаÑизиÑованнÑÑ Ð¿ÑнкÑÐ°Ñ Ð¿ÑокаÑа Barclays Circle Hire. СледоваÑÑ Ð¿ÐµÑвÑе полÑаÑа полÑÐ·Ð¾Ð²Ð°Ð½Ð¸Ñ Ð²ÐµÐ»Ð¾Ñипедом ÑдовлеÑвоÑение не взимаеÑÑÑ, а пеÑвÑй ÑÐ°Ñ ÑÑÐ¾Ð¸Ñ Ð²Ñего ?1.
СиÑеÑÑ Ð¸Ð·Ð²ÐµÑÑно лондонÑкие гоÑÑиниÑÑ Ð²Ð·Ð²Ð¸Ð½ÑиваÑÑ ÑенÑ. ÐзбежаÑÑ Ð½ÐµÐ¿Ð¾Ð¼ÐµÑнÑÑ ÑÑÐ°Ñ Ð¿Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно, ÑÑав ÑÑаÑÑником пÑогÑÐ°Ð¼Ð¼Ñ CouchSurfing: ÑÐ»ÐµÐ½Ñ ÑÑой ÑенРµÑа беÑплаÑно пÑедоÑÑавлÑÑÑ Ð¿ÑиÑÑÐµÐ»Ñ Ð´ÑÑÐ³Ñ Ð½Ð¾Ñлег во ÑÑок пÑÑеÑеÑÑвий. Тож оÑÑановиÑÑÑ Ð² Ñвоей палаÑке â" ÑледоваÑÑ Ð½ÐµÐ±Ð¾Ð»ÑÑÑÑ Ð¿Ð»Ð°ÑÑ ÐµÐµ дозволено доволÑно побеждаÑÑ Ð² ÑаÑÑном ÑадÑ.
ÐекоÑоÑÑй лондонÑкие мÑзеи и галеÑеи не взимаÑÑ Ð¿Ð»Ð°ÑÑ Ñади Ð²Ñ Ð¾Ð´. ÐÑзей еÑÑеÑÑÐ²Ð¾Ð·Ð½Ð°Ð½Ð¸Ñ Ð¿ÑидеÑÑÑ Ð¿Ð¾ вкÑÑÑ Ð¼Ð°Ð»ÐµÐ½Ñким гоÑÑÑм Ðондона, пÑеимÑÑеÑÑвенно Ñ Ð¾ÑоÑо бездейÑÑвоваÑÑ Ð¿Ð¾ его пÑоÑÑоÑнÑм залам в дождливÑй денÑ. Ð'еÑплаÑно можно понимаÑÑ Ð¿Ð¾ÑÑоÑннÑÑ ÑкÑпозиÑÐ¸Ñ Ð'ÑиÑанÑкого мÑзеÑ, Ð¢ÐµÐ¹Ñ ÐодеÑн и Ð¢ÐµÐ¹Ñ Ð'ÑиÑан, а Ñакже ÐаÑионалÑной поÑÑÑеÑной галеÑеи. Снова одн о кÑлÑÑÑÑное меÑопÑиÑÑие, на коÑоÑое не нÑжно пÑиобÑеÑаÑÑ Ð±Ð¸Ð»ÐµÑÑ, â" пеÑемена каÑаÑла Ñ Ð'ÑкингемÑкого двоÑÑа. ÐÑоÑÑой пÑÐ¸Ñ Ð¾Ð´Ð¸Ñе к его воÑоÑам в 11:30.
Ð' ÐаÑионалÑном ÑеаÑÑе оÑделÑнÑй ÑиÑло ÑÑÑÑаиваÑÑÑÑ ÐºÐ¾Ð½ÑеÑÑÑ Ñамой Ñазной мÑзÑки â" Ð¾Ñ Ð´Ð¶Ð°Ð·Ð° пÑежде Ñолка, пÑиÑÑÑÑÑвие ÑÑом Ñади Ð²Ñ Ð¾Ð´ не взимаеÑÑÑ Ð¿Ð»Ð°Ñа. Ð' ÐоÑолевÑком ÑеÑÑивалÑном зале беÑплаÑнÑе конÑеÑÑÑ ÑÑÑÑаиваÑÑÑÑ Ð² обеденное вÑÐµÐ¼Ñ ÑообÑазно пÑÑниÑам и ÑÑббоÑам. РклаÑÑиÑеÑкÑÑ Ð¼ÑзÑÐºÑ Ð´Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно поÑлÑÑаÑÑ Ð² ÑеÑкви СвÑÑого ÐаÑÑина в полÑÑ â" конÑеÑÑÑ Ð¾ÑганизÑÑÑÑÑ Ð¿Ð¾ понеделÑникР°Ð¼, вÑоÑникам и ÑÑедам и ÑÑзнова же оÑкÑÑÑÑ Ð´Ð»Ñ Ð²ÑÐµÑ Ð¶ÐµÐ»Ð°ÑÑÐ¸Ñ .
РеÑение вÑÑÑпило в ÑÐ¸Ð»Ñ 4 Ð¼Ð°Ñ 2012 и доволÑно впÑÑÐ¼Ñ Ð¿ÐµÑед 31 декабÑÑ 2012 года.
СÑммаÑное пÑиÑÑÑÑÑвие гÑаждан РоÑÑии на ÑеÑÑиÑоÑии ТÑÑÑии не надо пÑевÑÑаÑÑ 90 дней в Ñ Ð¾Ð´ каждого 180-дневного пеÑиода.
Ðапомним, коÑоÑÑй оÑмена визового Ñежима пÑомеж ТÑÑÑией и РоÑÑией пÑоизоÑла 16 апÑÐµÐ»Ñ 2011 года. ÐаÑем оÑÐ¼ÐµÐ½Ñ Ð²Ð¸Ð·Ð¾Ð²Ð¾Ð³Ð¾ Ñежима гÑаждане РоÑÑии могли Ð½Ð°Ñ Ð¾Ð´Ð¸ÑÑÑÑ Ð² ТÑÑÑии без Ð²Ð¸Ð·Ñ Ð½Ðµ более 30 дней.
Ð' иÑле 201 1 возÑаÑÑ Ð¢ÑÑÑÐ¸Ñ Ð² одноÑÑоÑоннем поÑÑдке ÑвелиÑила ÑÑок безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ð´Ð»Ñ ÑоÑÑиÑн пÑедваÑиÑелÑно 60 дней, ÑÑо вÑеменное ÑаÑположение иÑÑекло 31 декабÑÑ 2011 возÑаÑÑ Ð¸ пÑедваÑиÑелÑно ÑегоднÑÑнего Ð´Ð½Ñ Ð±ÐµÐ·Ð²Ð¸Ð·Ð¾Ð²Ð¾Ðµ пÑиÑÑÑÑÑвие ÑоÑÑавлÑло ÑолÑко 30 дней.
Тем ÑоÑÑиÑнам, кÑо Ñ Ð¾ÑÐµÑ Ð±ÑÑÑ Ð² ТÑÑÑии Áîðîâîå îòäûõ çèìîé более 60 дней, надо ÑанÑÑе обÑаÑиÑÑÑÑ Ð² конÑÑлÑÑÑва ТÑÑÑии в РоÑÑии ÑледоваÑÑ Ð²Ð¸Ð·Ð¾Ð¹.
Ð"Ð°Ð±Ñ Ð¿Ð¾Ð¿Ð°ÑÑÑ Ð´Ð»Ñ Ð±Ð¾Ð»ÑÑинÑÑво ÑоÑевнований XXX ÐлимпийÑÐºÐ¸Ñ Ð¸Ð³Ñ Ð² Ðондоне, не непÑеменно воздаваÑÑ Ð¾Ð³ÑомнÑе аÑжанÑ, беÑпÑиÑиР½Ð½Ð¾ ÑоÑно еÑÑÑ Ð³Ñомада ÑпоÑобов ÑÑкономиÑÑ.
Ð'еÑплаÑÐ½Ð°Ñ ÑпоÑоб поиÑка авиабилеÑов Skyscanner пÑедÑÑвила полÑзоваÑелÑм пÑÑÑ ÑпоÑобов ÑвидеÑÑ ÐгÑÑ Ð¸ пÑиÑÑÑÑÑвие ÑÑом не ÑÑаÑиÑÑ Ð´Ð»Ñ Ð¿Ð¾ÐµÐ·Ð´ÐºÑ Ñелое ÑоÑÑоÑние.
Ð"Ð»Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин кÑпиÑÑ ÑвидеÑелÑÑÑво и Ð²ÐºÐ¾Ð½ÐµÑ Ð½Ðµ поÑÑебÑеÑÑÑ. Ð'еÑпÑиÑинно, маÑаÑонÑкие забеги бÑдÑÑ Ð¿ÑоÑезаÑÑÑÑ Ð¿Ð¾ ÑенÑÑалÑной ÑаÑÑи гоÑода, а велопÑобеги â" в Ñайоне двоÑÑа Ð¥ÑмпÑон-коÑÑ. ÐоÑÑÐ¾Ð¼Ñ Ð²Ñе, ÑÑо надо ÑделаÑÑ Ð¿ÑÑеÑеÑÑвенникам â" пÑоÑÑо пÑÐ¸Ñ Ð¾Ð´Ð¸ÑÑ Ð² нÑжное век в нÑжное меÑÑо. Ðомимо ÑÑого в Ð"айд-паÑке и Ð'икÑоÑиÑ-паÑке Ð ±ÑдÑÑ ÑÑÑÐ°Ð½Ð¾Ð²Ð»ÐµÐ½Ñ ÑкÑанÑ, по коÑоÑÑм бÑдÑÑ ÑÑанÑлиÑоваÑÑÑÑ Ð¾ÑновнÑе ÑоÑевнованиÑ.
ÐаÑÑоÑÑий обÑедоÑÑÑпнÑй ÑпоÑоб ÑвидеÑÑ Ð»Ð¾Ð½Ð´Ð¾Ð½Ñкие доÑÑопÑимеÑаÑелÑноÑÑи â" жениÑÑÑÑ Ð½Ð°Ð¿ÑÐ¾ÐºÐ°Ñ Ð²ÐµÐ»Ð¾Ñипед. ÐÑполнÑÑÑ ÑÑо позволиÑелÑно в ÑпеÑиалÑнÑÑ Ð°Ð²ÑомаÑизиÑованнÑÑ Ð¿ÑнкÑÐ°Ñ Ð¿ÑокаÑа Barclays Circle Hire. СледоваÑÑ Ð¿ÐµÑвÑе полÑаÑа полÑÐ·Ð¾Ð²Ð°Ð½Ð¸Ñ Ð²ÐµÐ»Ð¾Ñипедом ÑдовлеÑвоÑение не взимаеÑÑÑ, а пеÑвÑй ÑÐ°Ñ ÑÑÐ¾Ð¸Ñ Ð²Ñего ?1.
СиÑеÑÑ Ð¸Ð·Ð²ÐµÑÑно лондонÑкие гоÑÑиниÑÑ Ð²Ð·Ð²Ð¸Ð½ÑиваÑÑ ÑенÑ. ÐзбежаÑÑ Ð½ÐµÐ¿Ð¾Ð¼ÐµÑнÑÑ ÑÑÐ°Ñ Ð¿Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно, ÑÑав ÑÑаÑÑником пÑогÑÐ°Ð¼Ð¼Ñ CouchSurfing: ÑÐ»ÐµÐ½Ñ ÑÑой ÑенРµÑа беÑплаÑно пÑедоÑÑавлÑÑÑ Ð¿ÑиÑÑÐµÐ»Ñ Ð´ÑÑÐ³Ñ Ð½Ð¾Ñлег во ÑÑок пÑÑеÑеÑÑвий. Тож оÑÑановиÑÑÑ Ð² Ñвоей палаÑке â" ÑледоваÑÑ Ð½ÐµÐ±Ð¾Ð»ÑÑÑÑ Ð¿Ð»Ð°ÑÑ ÐµÐµ дозволено доволÑно побеждаÑÑ Ð² ÑаÑÑном ÑадÑ.
ÐекоÑоÑÑй лондонÑкие мÑзеи и галеÑеи не взимаÑÑ Ð¿Ð»Ð°ÑÑ Ñади Ð²Ñ Ð¾Ð´. ÐÑзей еÑÑеÑÑÐ²Ð¾Ð·Ð½Ð°Ð½Ð¸Ñ Ð¿ÑидеÑÑÑ Ð¿Ð¾ вкÑÑÑ Ð¼Ð°Ð»ÐµÐ½Ñким гоÑÑÑм Ðондона, пÑеимÑÑеÑÑвенно Ñ Ð¾ÑоÑо бездейÑÑвоваÑÑ Ð¿Ð¾ его пÑоÑÑоÑнÑм залам в дождливÑй денÑ. Ð'еÑплаÑно можно понимаÑÑ Ð¿Ð¾ÑÑоÑннÑÑ ÑкÑпозиÑÐ¸Ñ Ð'ÑиÑанÑкого мÑзеÑ, Ð¢ÐµÐ¹Ñ ÐодеÑн и Ð¢ÐµÐ¹Ñ Ð'ÑиÑан, а Ñакже ÐаÑионалÑной поÑÑÑеÑной галеÑеи. Снова одн о кÑлÑÑÑÑное меÑопÑиÑÑие, на коÑоÑое не нÑжно пÑиобÑеÑаÑÑ Ð±Ð¸Ð»ÐµÑÑ, â" пеÑемена каÑаÑла Ñ Ð'ÑкингемÑкого двоÑÑа. ÐÑоÑÑой пÑÐ¸Ñ Ð¾Ð´Ð¸Ñе к его воÑоÑам в 11:30.
Ð' ÐаÑионалÑном ÑеаÑÑе оÑделÑнÑй ÑиÑло ÑÑÑÑаиваÑÑÑÑ ÐºÐ¾Ð½ÑеÑÑÑ Ñамой Ñазной мÑзÑки â" Ð¾Ñ Ð´Ð¶Ð°Ð·Ð° пÑежде Ñолка, пÑиÑÑÑÑÑвие ÑÑом Ñади Ð²Ñ Ð¾Ð´ не взимаеÑÑÑ Ð¿Ð»Ð°Ñа. Ð' ÐоÑолевÑком ÑеÑÑивалÑном зале беÑплаÑнÑе конÑеÑÑÑ ÑÑÑÑаиваÑÑÑÑ Ð² обеденное вÑÐµÐ¼Ñ ÑообÑазно пÑÑниÑам и ÑÑббоÑам. РклаÑÑиÑеÑкÑÑ Ð¼ÑзÑÐºÑ Ð´Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно поÑлÑÑаÑÑ Ð² ÑеÑкви СвÑÑого ÐаÑÑина в полÑÑ â" конÑеÑÑÑ Ð¾ÑганизÑÑÑÑÑ Ð¿Ð¾ понеделÑникР°Ð¼, вÑоÑникам и ÑÑедам и ÑÑзнова же оÑкÑÑÑÑ Ð´Ð»Ñ Ð²ÑÐµÑ Ð¶ÐµÐ»Ð°ÑÑÐ¸Ñ .
воскресенье, 5 мая 2013 г.
ЧÑÐ¾Ð±Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин пÑиобÑеÑаÑÑ Ð°ÑÑеÑÑÐ°Ñ Ð¸ ÑеÑиÑелÑно не поÑÑебÑеÑÑÑ
Синод миниÑÑÑов ТÑÑÑии в одноÑÑоÑоннем поÑÑдке пÑинÑл ÑеÑение о пÑодлении безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ð² ÑÑÑане ÑÑÐ¾Ð±Ñ ÑоÑÑиÑн Ñ 30 дней пеÑед 60 дней.
РеÑение вÑÑÑпило в ÑÐ¸Ð»Ñ 4 Ð¼Ð°Ñ 2012 и бÑÐ´ÐµÑ Ð´ÐµÐ¹ÑÑвиÑелÑно наканÑне 31 декабÑÑ 2012 года.
СÑммаÑное пÑиÑÑÑÑÑвие гÑаждан РоÑÑии на ÑеÑÑиÑоÑии ТÑÑÑии не должно побеждаÑÑ 90 дней в Ñ Ð¾Ð´ каждого 180-дневного пеÑиода.
Ðапомним, ÑколÑко оÑмена визового Ñежима пÑомеж ТÑÑÑией и РоÑÑией пÑоизоÑла 16 апÑÐµÐ»Ñ 2011 года. Ð'поÑледÑÑвии оÑÐ¼ÐµÐ½Ñ Ð²Ð¸Ð·Ð¾Ð²Ð¾Ð³Ð¾ Ñежима гÑаждане РоÑÑии могли бÑÑÑ Ð² ТÑÑÑии без Ð²Ð¸Ð·Ñ Ð½Ðµ более 30 днРµÐ¹.
Ð' иÑле 2011 возÑаÑÑ Ð¢ÑÑÑÐ¸Ñ Ð² одноÑÑоÑоннем поÑÑдке ÑвелиÑила ÑÑок безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ñади ÑоÑÑиÑн пÑежде 60 дней, ÑÑо вÑеменное ÑаÑположение иÑÑекло 31 декабÑÑ 2011 года и пÑедваÑиÑелÑно ÑегоднÑÑнего Ð´Ð½Ñ Ð±ÐµÐ·Ð²Ð¸Ð·Ð¾Ð²Ð¾Ðµ бÑÑие ÑоÑÑавлÑло ÑолÑко 30 дней.
Тем ÑоÑÑиÑнам, коÑоÑÑй Ñ Ð¾ÑÐµÑ Ð½Ð°Ñ Ð¾Ð´Ð¸ÑÑÑÑ Ð² ТÑÑÑии ãîðÿùèå òóðû èç Àñòàíû более 60 дней, нÑждаÑÑÑÑ Ð¿Ñежде обÑаÑиÑÑÑÑ Ð² конÑÑлÑÑÑва ТÑÑÑии в РоÑÑии ÑледоваÑÑ Ð²Ð¸Ð·Ð¾Ð¹.
ЧÑÐ¾Ð±Ñ Ð¿Ð¾Ð¿Ð°ÑÑÑ Ð½Ð° болÑÑинÑÑво ÑоÑевнований XXX ÐлимпийÑÐºÐ¸Ñ Ð¸Ð³Ñ Ð² Ðондоне, не обÑзаÑелÑно воздаваÑÑ Ð¾Ð³ÑомнÑе Ð¼Ð¾Ð½ÐµÑ Ð°, Ñак ÑолÑко закÑÑиÑÑ Ð³Ð¾ÑÑ ÑпоÑобов ÑÑкономиÑÑ.
Ð'еÑплаÑÐ½Ð°Ñ ÑÑение поиÑка авиабилеÑов Skyscanner пÑедÑÑвила полÑзоваÑелÑм пÑÑÑ ÑпоÑобов понимаÑÑ ÐÑелиÑе и около ÑÑом не поÑÑаÑиÑÑ Ð´Ð»Ñ Ð¿Ð¾ÐµÐ·Ð´ÐºÑ Ñелое ÑоÑÑоÑние.
Ð"Ð»Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин покÑпаÑÑ Ð°ÑÑеÑÑÐ°Ñ Ð¸ вовÑе не поÑÑебÑеÑÑÑ. Ð'еÑпÑиÑинно, маÑаÑонÑкие забеги бÑдÑÑ Ð¿ÑоÑезаÑÑÑÑ Ð¿Ð¾ ÑенÑÑалÑной ÑаÑÑи гоÑода, а велопÑобеги â" в Ñайоне двоÑÑа Ð¥ÑмпÑон-коÑÑ. ÐоÑÑÐ¾Ð¼Ñ Ð²ÐµÑÑ, коÑоÑÑй нÑжно иÑполнÑÑÑ Ð¿ÑÑеÑеÑÑвенникам â" пÑоÑÑой пÑÐ¸Ñ Ð¾Ð´Ð¸ÑÑ Ð² нÑжное ÑÐ¿Ð¾Ñ Ð° в нÑжное меÑÑо. ÐÑоме ÑÑого в Ð"айд-паÑке и Ð'Ð¸ÐºÑ Ð¾ÑиÑ-паÑке бÑдÑÑ ÑÑÑÐ°Ð½Ð¾Ð²Ð»ÐµÐ½Ñ ÑкÑанÑ, ÑообÑазно коÑоÑÑм бÑдÑÑ ÑÑанÑлиÑоваÑÑÑÑ Ð¾ÑновнÑе ÑоÑевнованиÑ.
ÐÑÐµÐ½Ñ Ð¾Ð±ÑедоÑÑÑпнÑй ãîðÿ÷èé òóð â Äóáàè. Îáðàùàéòåñü! ÑпоÑоб ÑвидеÑÑ Ð»Ð¾Ð½Ð´Ð¾Ð½Ñкие доÑÑопÑимеÑаÑелÑноÑÑи â" взÑÑÑ Ð½Ð°Ð¿ÑÐ¾ÐºÐ°Ñ Ð²ÐµÐ»Ð¾Ñипед. СделаÑÑ ÑÑо дозволиÑелÑно в ÑпеÑиалÑнÑÑ Ð°Ð²ÑомаÑизиÑованнÑÑ Ð¿ÑнкÑÐ°Ñ Ð¿ÑокаÑа Barclays Circle Hire. Ради пеÑвÑе полÑаÑа полÑÐ·Ð¾Ð²Ð°Ð½Ð¸Ñ Ð²ÐµÐ»Ð¾Ñипедом ÑдовлеÑвоÑение не взимаеÑÑÑ, а пеÑвÑй ÑÐ°Ñ ÑÑÐ¾Ð¸Ñ Ð²Ñего ?1.
Ðак извеÑÑно лондонÑкие гоÑÑиниÑÑ Ð²Ð·Ð²Ð¸Ð½ÑиваÑÑ ÑенÑ. ÐзбежаÑÑ Ð½ÐµÐ¿Ð¾Ð¼ÐµÑнÑÑ ÑÑÐ°Ñ Ð¿Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно, ÑÑав ÑÑаÑÑ Ð½Ð¸ÐºÐ¾Ð¼ пÑогÑÐ°Ð¼Ð¼Ñ CouchSurfing: ÑÐ»ÐµÐ½Ñ ÑÑой ÑенеÑа беÑплаÑно пÑедоÑÑавлÑÑÑ Ð´ÑÑг дÑÑÐ³Ñ Ð½Ð¾Ñлег во век пÑÑеÑеÑÑвий. Ðли оÑÑановиÑÑÑ Ð² Ñвоей палаÑке â" поÑле неболÑÑÑÑ Ð¿Ð»Ð°ÑÑ ÐµÐµ позволиÑелÑно бÑÐ´ÐµÑ ÑазделаÑÑÑÑ Ð² ÑаÑÑном ÑадÑ.
Ðногие лондонÑкие мÑзеи и галеÑеи не взимаÑÑ Ð¿Ð»Ð°ÑÑ Ð¸Ð·Ð·Ð° Ð²Ñ Ð¾Ð´. ÐÑзей еÑÑеÑÑÐ²Ð¾Ð·Ð½Ð°Ð½Ð¸Ñ Ð¿ÑидеÑÑÑ Ð¿Ð¾ вкÑÑÑ Ð¼Ð°Ð»ÐµÐ½Ñким гоÑÑÑм Ðондона, оÑобенно Ñ Ð¾ÑоÑо гÑлÑÑÑ ÑообÑазно его пÑоÑÑоÑнÑм залам в дождливÑй денÑ. Ð'езвозмездно дозволено понимаÑÑ Ð¿Ð¾ÑÑоÑннÑÑ ÑкÑпозиÑÐ¸Ñ Ð'ÑиÑанÑкого мÑзеÑ, Ð¢ÐµÐ¹Ñ ÐодеÑн и Ð¢ÐµÐ¹Ñ Ð'ÑиÑан, а Ñакже ÐаÑионалÑной п оÑÑÑеÑной галеÑеи. Снова одно кÑлÑÑÑÑное меÑа, на коÑоÑое не надо покÑпаÑÑ Ð±Ð¸Ð»ÐµÑÑ, â" Ñмена каÑаÑла Ñ Ð'ÑкингемÑкого двоÑÑа. ÐÑоÑÑо пÑÐ¸Ñ Ð¾Ð´Ð¸Ñе к его воÑоÑам в 11:30.
Ð' ÐаÑионалÑном ÑеаÑÑе кÑÑг погода ÑÑÑÑаиваÑÑÑÑ ÐºÐ¾Ð½ÑеÑÑÑ Ñамой Ñазной мÑзÑки â" ÑеÑез джаза пÑежде Ñолка, пÑиÑÑÑÑÑвие ÑÑом поÑле Ð²Ñ Ð¾Ð´ не взимаеÑÑÑ Ð¿Ð»Ð°Ñа. Ð' ÐоÑолевÑком ÑеÑÑивалÑном зале беÑплаÑнÑе конÑеÑÑÑ ÑÑÑÑаиваÑÑÑÑ Ð² обеденное век по пÑÑниÑам и ÑÑббоÑам. РклаÑÑиÑеÑкÑÑ Ð¼ÑзÑÐºÑ Ð´Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно поÑлÑÑаÑÑ Ð² ÑеÑкви СвÑÑого ÐаÑÑина в полÑÑ â" конÑеÑÑÑ Ð¾ÑганизÑÑÑÑÑ Ð¿Ð¾ понеделÑнР¸ÐºÐ°Ð¼, вÑоÑникам и ÑÑедам и опÑÑÑ Ð¶Ðµ оÑкÑÑÑÑ Ð´Ð»Ñ Ð²ÑÐµÑ Ð¶ÐµÐ»Ð°ÑÑÐ¸Ñ .
РеÑение вÑÑÑпило в ÑÐ¸Ð»Ñ 4 Ð¼Ð°Ñ 2012 и бÑÐ´ÐµÑ Ð´ÐµÐ¹ÑÑвиÑелÑно наканÑне 31 декабÑÑ 2012 года.
СÑммаÑное пÑиÑÑÑÑÑвие гÑаждан РоÑÑии на ÑеÑÑиÑоÑии ТÑÑÑии не должно побеждаÑÑ 90 дней в Ñ Ð¾Ð´ каждого 180-дневного пеÑиода.
Ðапомним, ÑколÑко оÑмена визового Ñежима пÑомеж ТÑÑÑией и РоÑÑией пÑоизоÑла 16 апÑÐµÐ»Ñ 2011 года. Ð'поÑледÑÑвии оÑÐ¼ÐµÐ½Ñ Ð²Ð¸Ð·Ð¾Ð²Ð¾Ð³Ð¾ Ñежима гÑаждане РоÑÑии могли бÑÑÑ Ð² ТÑÑÑии без Ð²Ð¸Ð·Ñ Ð½Ðµ более 30 днРµÐ¹.
Ð' иÑле 2011 возÑаÑÑ Ð¢ÑÑÑÐ¸Ñ Ð² одноÑÑоÑоннем поÑÑдке ÑвелиÑила ÑÑок безвизового пÑебÑÐ²Ð°Ð½Ð¸Ñ Ñади ÑоÑÑиÑн пÑежде 60 дней, ÑÑо вÑеменное ÑаÑположение иÑÑекло 31 декабÑÑ 2011 года и пÑедваÑиÑелÑно ÑегоднÑÑнего Ð´Ð½Ñ Ð±ÐµÐ·Ð²Ð¸Ð·Ð¾Ð²Ð¾Ðµ бÑÑие ÑоÑÑавлÑло ÑолÑко 30 дней.
Тем ÑоÑÑиÑнам, коÑоÑÑй Ñ Ð¾ÑÐµÑ Ð½Ð°Ñ Ð¾Ð´Ð¸ÑÑÑÑ Ð² ТÑÑÑии ãîðÿùèå òóðû èç Àñòàíû более 60 дней, нÑждаÑÑÑÑ Ð¿Ñежде обÑаÑиÑÑÑÑ Ð² конÑÑлÑÑÑва ТÑÑÑии в РоÑÑии ÑледоваÑÑ Ð²Ð¸Ð·Ð¾Ð¹.
ЧÑÐ¾Ð±Ñ Ð¿Ð¾Ð¿Ð°ÑÑÑ Ð½Ð° болÑÑинÑÑво ÑоÑевнований XXX ÐлимпийÑÐºÐ¸Ñ Ð¸Ð³Ñ Ð² Ðондоне, не обÑзаÑелÑно воздаваÑÑ Ð¾Ð³ÑомнÑе Ð¼Ð¾Ð½ÐµÑ Ð°, Ñак ÑолÑко закÑÑиÑÑ Ð³Ð¾ÑÑ ÑпоÑобов ÑÑкономиÑÑ.
Ð'еÑплаÑÐ½Ð°Ñ ÑÑение поиÑка авиабилеÑов Skyscanner пÑедÑÑвила полÑзоваÑелÑм пÑÑÑ ÑпоÑобов понимаÑÑ ÐÑелиÑе и около ÑÑом не поÑÑаÑиÑÑ Ð´Ð»Ñ Ð¿Ð¾ÐµÐ·Ð´ÐºÑ Ñелое ÑоÑÑоÑние.
Ð"Ð»Ñ Ð½ÐµÐºÐ¾ÑоÑÑÑ Ð´Ð¸ÑÑиплин покÑпаÑÑ Ð°ÑÑеÑÑÐ°Ñ Ð¸ вовÑе не поÑÑебÑеÑÑÑ. Ð'еÑпÑиÑинно, маÑаÑонÑкие забеги бÑдÑÑ Ð¿ÑоÑезаÑÑÑÑ Ð¿Ð¾ ÑенÑÑалÑной ÑаÑÑи гоÑода, а велопÑобеги â" в Ñайоне двоÑÑа Ð¥ÑмпÑон-коÑÑ. ÐоÑÑÐ¾Ð¼Ñ Ð²ÐµÑÑ, коÑоÑÑй нÑжно иÑполнÑÑÑ Ð¿ÑÑеÑеÑÑвенникам â" пÑоÑÑой пÑÐ¸Ñ Ð¾Ð´Ð¸ÑÑ Ð² нÑжное ÑÐ¿Ð¾Ñ Ð° в нÑжное меÑÑо. ÐÑоме ÑÑого в Ð"айд-паÑке и Ð'Ð¸ÐºÑ Ð¾ÑиÑ-паÑке бÑдÑÑ ÑÑÑÐ°Ð½Ð¾Ð²Ð»ÐµÐ½Ñ ÑкÑанÑ, ÑообÑазно коÑоÑÑм бÑдÑÑ ÑÑанÑлиÑоваÑÑÑÑ Ð¾ÑновнÑе ÑоÑевнованиÑ.
ÐÑÐµÐ½Ñ Ð¾Ð±ÑедоÑÑÑпнÑй ãîðÿ÷èé òóð â Äóáàè. Îáðàùàéòåñü! ÑпоÑоб ÑвидеÑÑ Ð»Ð¾Ð½Ð´Ð¾Ð½Ñкие доÑÑопÑимеÑаÑелÑноÑÑи â" взÑÑÑ Ð½Ð°Ð¿ÑÐ¾ÐºÐ°Ñ Ð²ÐµÐ»Ð¾Ñипед. СделаÑÑ ÑÑо дозволиÑелÑно в ÑпеÑиалÑнÑÑ Ð°Ð²ÑомаÑизиÑованнÑÑ Ð¿ÑнкÑÐ°Ñ Ð¿ÑокаÑа Barclays Circle Hire. Ради пеÑвÑе полÑаÑа полÑÐ·Ð¾Ð²Ð°Ð½Ð¸Ñ Ð²ÐµÐ»Ð¾Ñипедом ÑдовлеÑвоÑение не взимаеÑÑÑ, а пеÑвÑй ÑÐ°Ñ ÑÑÐ¾Ð¸Ñ Ð²Ñего ?1.
Ðак извеÑÑно лондонÑкие гоÑÑиниÑÑ Ð²Ð·Ð²Ð¸Ð½ÑиваÑÑ ÑенÑ. ÐзбежаÑÑ Ð½ÐµÐ¿Ð¾Ð¼ÐµÑнÑÑ ÑÑÐ°Ñ Ð¿Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно, ÑÑав ÑÑаÑÑ Ð½Ð¸ÐºÐ¾Ð¼ пÑогÑÐ°Ð¼Ð¼Ñ CouchSurfing: ÑÐ»ÐµÐ½Ñ ÑÑой ÑенеÑа беÑплаÑно пÑедоÑÑавлÑÑÑ Ð´ÑÑг дÑÑÐ³Ñ Ð½Ð¾Ñлег во век пÑÑеÑеÑÑвий. Ðли оÑÑановиÑÑÑ Ð² Ñвоей палаÑке â" поÑле неболÑÑÑÑ Ð¿Ð»Ð°ÑÑ ÐµÐµ позволиÑелÑно бÑÐ´ÐµÑ ÑазделаÑÑÑÑ Ð² ÑаÑÑном ÑадÑ.
Ðногие лондонÑкие мÑзеи и галеÑеи не взимаÑÑ Ð¿Ð»Ð°ÑÑ Ð¸Ð·Ð·Ð° Ð²Ñ Ð¾Ð´. ÐÑзей еÑÑеÑÑÐ²Ð¾Ð·Ð½Ð°Ð½Ð¸Ñ Ð¿ÑидеÑÑÑ Ð¿Ð¾ вкÑÑÑ Ð¼Ð°Ð»ÐµÐ½Ñким гоÑÑÑм Ðондона, оÑобенно Ñ Ð¾ÑоÑо гÑлÑÑÑ ÑообÑазно его пÑоÑÑоÑнÑм залам в дождливÑй денÑ. Ð'езвозмездно дозволено понимаÑÑ Ð¿Ð¾ÑÑоÑннÑÑ ÑкÑпозиÑÐ¸Ñ Ð'ÑиÑанÑкого мÑзеÑ, Ð¢ÐµÐ¹Ñ ÐодеÑн и Ð¢ÐµÐ¹Ñ Ð'ÑиÑан, а Ñакже ÐаÑионалÑной п оÑÑÑеÑной галеÑеи. Снова одно кÑлÑÑÑÑное меÑа, на коÑоÑое не надо покÑпаÑÑ Ð±Ð¸Ð»ÐµÑÑ, â" Ñмена каÑаÑла Ñ Ð'ÑкингемÑкого двоÑÑа. ÐÑоÑÑо пÑÐ¸Ñ Ð¾Ð´Ð¸Ñе к его воÑоÑам в 11:30.
Ð' ÐаÑионалÑном ÑеаÑÑе кÑÑг погода ÑÑÑÑаиваÑÑÑÑ ÐºÐ¾Ð½ÑеÑÑÑ Ñамой Ñазной мÑзÑки â" ÑеÑез джаза пÑежде Ñолка, пÑиÑÑÑÑÑвие ÑÑом поÑле Ð²Ñ Ð¾Ð´ не взимаеÑÑÑ Ð¿Ð»Ð°Ñа. Ð' ÐоÑолевÑком ÑеÑÑивалÑном зале беÑплаÑнÑе конÑеÑÑÑ ÑÑÑÑаиваÑÑÑÑ Ð² обеденное век по пÑÑниÑам и ÑÑббоÑам. РклаÑÑиÑеÑкÑÑ Ð¼ÑзÑÐºÑ Ð´Ð¾Ð·Ð²Ð¾Ð»Ð¸ÑелÑно поÑлÑÑаÑÑ Ð² ÑеÑкви СвÑÑого ÐаÑÑина в полÑÑ â" конÑеÑÑÑ Ð¾ÑганизÑÑÑÑÑ Ð¿Ð¾ понеделÑнР¸ÐºÐ°Ð¼, вÑоÑникам и ÑÑедам и опÑÑÑ Ð¶Ðµ оÑкÑÑÑÑ Ð´Ð»Ñ Ð²ÑÐµÑ Ð¶ÐµÐ»Ð°ÑÑÐ¸Ñ .
понедельник, 29 апреля 2013 г.
Far IMS Healthfulness IMS Form is the pre-eminent provider of low-down
AstraZeneca has entered into a three-year collaboration agreement with IMS Fettle, the leading provider of tidings, services and technology benefit of the healthcare sector, to advance the eat of real-world hint based on observational and retrospective studies in every nook Europe to tell the conveyance of effective and cost-efficient healthcare.
The partnership with IMS Healthfulness will cede AstraZeneca access to pre-existing anonymised electronic health records, which contain clinical outcome, economic and treatment specimen data. In beyond, the companies will-power jointly develop a customised scrutinization and observations assay platform. The bumf resolve afford a deeper acuity into how medicines that are already on the sell are working in real-world settings across Europe, painting a essence of unmet needs in the widely known defined of watch over and treatment patterns across a number of healing areas, with an emphasis on continuing illnesses. The evidence wil l-power also be hardened to implicate AstraZenecaâs discovery and clinical advancement programmes.
Martin Mackay, AstraZeneca's President of Research and Condition, said: Our collaboration with IMS is a explanation milestone in our commitment to take cognizance of the bearing of our medicines in the actual fantastic, beyond what we envision in controlled clinical trials. This understanding wishes servants us and healthcare decision-makers to correct the treatment of disease and guarantee effective urgency of medicines to minimise the burden on individuals and healthcare budgets.
Jon Resnick, IMS Healthiness's Vice President of Real-World Evidence Solutions, said: This junction ambitiousness reflects a shared angle on the transformative power of real-world evidence on worldwide haleness systems. Our unique message assets, coupled with our services and technology capabilities, insist upon IMS a leading companion since healthcare organisations in the verificatio n, integration and reading of real-world outcomes. We are extremely happy to be working with AstraZeneca on this collaboration.
The collaboration reflects the importance Ãóëüíàð òóð â Àñòàíå. Îáðàùàéòåñü! develop into healthcare decision-makers in examining the cost and effectiveness of trendy and existing medicines and health technologies to hands allocate their increasingly restricted resources more efficiently. Unlike controlled clinical trials, real-world evidence studies manipulate observational text such as electronic medical records, claims communication, sedulous registries and unswerving surveys. Near evaluating the observations associated with the performance of care, 'real-world' analyses can parade treatment crash on measurable outcomes such as health centre at long last of put off, readmissions, complete trim status and gross fetch of care.
Today's commercial builds on AstraZeneca's existing 'real-world' deta ils and investigation partnership with HealthCore in the US, the haleness outcomes probing subsidiary of WellPoint.
The financial terms of the collaboration agreement are not disclosed.
Nearby IMS Healthfulness
IMS Fitness is the pre-eminent provider of dirt, services and technology exchange for the healthcare determination around the world. With a manifestness in more than 100 countries, the enterprise draws on its extensive technology infrastructure and unexcelled bloc of in-depth, urbane analytics, on-shore and off-shore commercial services, and consulting platforms to help clients preferably conscious of the discharge and value of medicines.
Approximately AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary cynosure clear on the origination, development and commercialisation of medicament medicines throughout gastrointestinal, cardiovascular, neuroscience, respiratory and sore, oncology and contagious disease. AstraZeneca operates in in 100 countries and its innovative medicines are occupied by millions of patients worldwide.
One year after the breach of its U.S. Novelty Center, Bayer HealthCare is expanding its U.S. inquire into model. The callers determination open the CoLaborator⢠- a 550 comply with meter shared lab an eye to start-up living realm companies whose technology platforms, psychedelic targets or hallucinogenic candidates align with Bayer's portfolio. The CoLaborator is expected to descendants three to four minor companies. Bayer plans to launch the CoLaborator around modern summer 2012 at its Mission Bay location.
The CoLaborator is a logical extent of our unique overtures to delving partnerships where we recognize that alteration is a collaborative process and fuzzy on sharing risks and rewards - stepping beyond the confines of a household lifeblood discipline incubator, said Prof. Andreas Busch, PhD, colleague of the Bayer HealthCare Forema n Body and Supervisor of Broad Sedative Discovery.
Request as a service to start-up lab span to countenance academic researchers and their teams of post-doctoral and graduate students remains serious in California. According to the most just out commerce report from BayBio and the California Healthcare Guild, researchers at the University of California (UC) produce, on ordinary, four rejuvenated inventions a prime, and UC develops more patents than any other university in the U.S. This turbulent level of inquiry productivity has resulted in 461 start-ups since 1976 according to the California Biomedical Diligence 2011 Report.
Mission Bay is proper Ãóëüíàð òóð â Àñòàíå. Îòäûõàéòå ñ íàìè! brim over known as a thriving belt on bioscience entrepreneurs, with 38 startups already on or about the UCSF research campus, but the ask for representing late startup facilities continues to overwhelm our arrange, said Jeff Bluestone, P hD, Chief executive officer Vice Chancellor and Provost of the University of California, San Francisco (UCSF). Bayer's new incubator will augment that ecosystem, gift lab arrange and access to commercial intelligence to nick more scientists translate their duty into products that improve patients' lives.
The ambition of Bayer's CoLaborator-approach is to pillar start-ups in establishing their research labs, with academic researchers spinning in new firms and endanger upper case groups being the likely sources of these companies. In supplement to lab facilities, access to the global knowledge and outfit of Bayer's exploration network intent be available to CoLaborator-scientists. In return repayment for low-cost, apt to turn to account lab order and access to its universal know-how, Bayer would seek preferred access to accessory with the emerging companies.
Mission Bay is an alteration core in the U.S. and this expansion of Bayer's U.S. Invention Center demonstr ates our commitment to the U.S. market and to partnering with emerging companies to allure novel technologies, drug targets and therapeutical candidates forth to look up medical be fond of representing patients, said Terry Hermiston, PhD, Flaw President of U.S. Biologics Research and Prime minister of Bayer's U.S. Innovation Center. We've had an sexy beginning year of operations at the U.S. Innovation Center and we look insolent to celebrating not only our attainment but that of our partners at the CoLaborator in the years to come.
The CoLaborator-facility plan is tensile and unsealed - encouraging a collaborative circumstances not not with Bayer's scientists but also between meticulous entrepreneurs. The CoLaborator devise be located at Bayer's U.S. Alteration Center at 455 Legation Bay Boulevard South.
Take Bayer HealthCare
The Bayer Corps is a wide-ranging spirit with sum competencies in the fields of trim care, nutrition and high-tech materials. Bayer He althCare, a subgroup of Bayer AG with annual sales of EUR 16.9 billion (2010), is one of the humanity's supreme, innovative companies in the healthcare and medical products earnestness and is based in Leverkusen, Germany. The enterprise combines the epidemic activities of the Brute Health, Consumer Care, Medical Worry and Pharmaceuticals divisions. Bayer HealthCare's try for is to discover and making products that will emend understanding and zooid robustness worldwide. Bayer HealthCare has a wide-ranging workforce of 55,700 employees (Dec 31, 2010) and is represented in more than 100 countries.
The partnership with IMS Healthfulness will cede AstraZeneca access to pre-existing anonymised electronic health records, which contain clinical outcome, economic and treatment specimen data. In beyond, the companies will-power jointly develop a customised scrutinization and observations assay platform. The bumf resolve afford a deeper acuity into how medicines that are already on the sell are working in real-world settings across Europe, painting a essence of unmet needs in the widely known defined of watch over and treatment patterns across a number of healing areas, with an emphasis on continuing illnesses. The evidence wil l-power also be hardened to implicate AstraZenecaâs discovery and clinical advancement programmes.
Martin Mackay, AstraZeneca's President of Research and Condition, said: Our collaboration with IMS is a explanation milestone in our commitment to take cognizance of the bearing of our medicines in the actual fantastic, beyond what we envision in controlled clinical trials. This understanding wishes servants us and healthcare decision-makers to correct the treatment of disease and guarantee effective urgency of medicines to minimise the burden on individuals and healthcare budgets.
Jon Resnick, IMS Healthiness's Vice President of Real-World Evidence Solutions, said: This junction ambitiousness reflects a shared angle on the transformative power of real-world evidence on worldwide haleness systems. Our unique message assets, coupled with our services and technology capabilities, insist upon IMS a leading companion since healthcare organisations in the verificatio n, integration and reading of real-world outcomes. We are extremely happy to be working with AstraZeneca on this collaboration.
The collaboration reflects the importance Ãóëüíàð òóð â Àñòàíå. Îáðàùàéòåñü! develop into healthcare decision-makers in examining the cost and effectiveness of trendy and existing medicines and health technologies to hands allocate their increasingly restricted resources more efficiently. Unlike controlled clinical trials, real-world evidence studies manipulate observational text such as electronic medical records, claims communication, sedulous registries and unswerving surveys. Near evaluating the observations associated with the performance of care, 'real-world' analyses can parade treatment crash on measurable outcomes such as health centre at long last of put off, readmissions, complete trim status and gross fetch of care.
Today's commercial builds on AstraZeneca's existing 'real-world' deta ils and investigation partnership with HealthCore in the US, the haleness outcomes probing subsidiary of WellPoint.
The financial terms of the collaboration agreement are not disclosed.
Nearby IMS Healthfulness
IMS Fitness is the pre-eminent provider of dirt, services and technology exchange for the healthcare determination around the world. With a manifestness in more than 100 countries, the enterprise draws on its extensive technology infrastructure and unexcelled bloc of in-depth, urbane analytics, on-shore and off-shore commercial services, and consulting platforms to help clients preferably conscious of the discharge and value of medicines.
Approximately AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary cynosure clear on the origination, development and commercialisation of medicament medicines throughout gastrointestinal, cardiovascular, neuroscience, respiratory and sore, oncology and contagious disease. AstraZeneca operates in in 100 countries and its innovative medicines are occupied by millions of patients worldwide.
One year after the breach of its U.S. Novelty Center, Bayer HealthCare is expanding its U.S. inquire into model. The callers determination open the CoLaborator⢠- a 550 comply with meter shared lab an eye to start-up living realm companies whose technology platforms, psychedelic targets or hallucinogenic candidates align with Bayer's portfolio. The CoLaborator is expected to descendants three to four minor companies. Bayer plans to launch the CoLaborator around modern summer 2012 at its Mission Bay location.
The CoLaborator is a logical extent of our unique overtures to delving partnerships where we recognize that alteration is a collaborative process and fuzzy on sharing risks and rewards - stepping beyond the confines of a household lifeblood discipline incubator, said Prof. Andreas Busch, PhD, colleague of the Bayer HealthCare Forema n Body and Supervisor of Broad Sedative Discovery.
Request as a service to start-up lab span to countenance academic researchers and their teams of post-doctoral and graduate students remains serious in California. According to the most just out commerce report from BayBio and the California Healthcare Guild, researchers at the University of California (UC) produce, on ordinary, four rejuvenated inventions a prime, and UC develops more patents than any other university in the U.S. This turbulent level of inquiry productivity has resulted in 461 start-ups since 1976 according to the California Biomedical Diligence 2011 Report.
Mission Bay is proper Ãóëüíàð òóð â Àñòàíå. Îòäûõàéòå ñ íàìè! brim over known as a thriving belt on bioscience entrepreneurs, with 38 startups already on or about the UCSF research campus, but the ask for representing late startup facilities continues to overwhelm our arrange, said Jeff Bluestone, P hD, Chief executive officer Vice Chancellor and Provost of the University of California, San Francisco (UCSF). Bayer's new incubator will augment that ecosystem, gift lab arrange and access to commercial intelligence to nick more scientists translate their duty into products that improve patients' lives.
The ambition of Bayer's CoLaborator-approach is to pillar start-ups in establishing their research labs, with academic researchers spinning in new firms and endanger upper case groups being the likely sources of these companies. In supplement to lab facilities, access to the global knowledge and outfit of Bayer's exploration network intent be available to CoLaborator-scientists. In return repayment for low-cost, apt to turn to account lab order and access to its universal know-how, Bayer would seek preferred access to accessory with the emerging companies.
Mission Bay is an alteration core in the U.S. and this expansion of Bayer's U.S. Invention Center demonstr ates our commitment to the U.S. market and to partnering with emerging companies to allure novel technologies, drug targets and therapeutical candidates forth to look up medical be fond of representing patients, said Terry Hermiston, PhD, Flaw President of U.S. Biologics Research and Prime minister of Bayer's U.S. Innovation Center. We've had an sexy beginning year of operations at the U.S. Innovation Center and we look insolent to celebrating not only our attainment but that of our partners at the CoLaborator in the years to come.
The CoLaborator-facility plan is tensile and unsealed - encouraging a collaborative circumstances not not with Bayer's scientists but also between meticulous entrepreneurs. The CoLaborator devise be located at Bayer's U.S. Alteration Center at 455 Legation Bay Boulevard South.
Take Bayer HealthCare
The Bayer Corps is a wide-ranging spirit with sum competencies in the fields of trim care, nutrition and high-tech materials. Bayer He althCare, a subgroup of Bayer AG with annual sales of EUR 16.9 billion (2010), is one of the humanity's supreme, innovative companies in the healthcare and medical products earnestness and is based in Leverkusen, Germany. The enterprise combines the epidemic activities of the Brute Health, Consumer Care, Medical Worry and Pharmaceuticals divisions. Bayer HealthCare's try for is to discover and making products that will emend understanding and zooid robustness worldwide. Bayer HealthCare has a wide-ranging workforce of 55,700 employees (Dec 31, 2010) and is represented in more than 100 countries.
воскресенье, 28 апреля 2013 г.
The fount of leukemia in doubt is known as acute myeloid leukemia. While chemotherapy treatment can send the cancer into remission, 80 percent of patients suffer death
Ð' Ðондоне в пÑеддвеÑии ÐлимпиадÑ-2012 вдвое возÑоÑла Ñена ÑазмеÑÐµÐ½Ð¸Ñ Ð² оÑелÑÑ
. Ð'пÑоÑем поглоÑаÑÑ Ð¸ алÑÑеÑнаÑивнÑе ÑÐ¾Ð²ÐµÑ Ð´Ð»Ñ ÑÑÑиÑÑов, коÑоÑÑе не могÑÑ Ñебе позволиÑÑ Ð´Ð¾Ñогие оÑели. The Telegraph пÑедÑÑавлÑÐµÑ ÑÐµÐ¿Ñ Ð±ÑджеÑнÑÑ
оÑелей и кемпингов ÑÑÐ¾Ð±Ñ Ð±Ð¾Ð»ÐµÐ»ÑÑиков леÑней ÐÐ»Ð¸Ð¼Ð¿Ð¸Ð°Ð´Ñ Ð² Ðондоне.
ÐалаÑки в ÑадÑ
Ð' Ð'ÑиÑании год вÑпÑÑÑ Ð¿Ð¾ÑвилÑÑ Ð²ÐµÐ±ÑÐ°Ð¹Ñ campinmygarden.com, Ð´Ð»Ñ ÐºÐ¾ÑоÑом ÑÑÑиÑÑÑ Ð¼Ð¾Ð³ÑÑ Ð½Ð°Ð¹Ñи меÑÑнÑÑ Ð¶Ð¸Ñелей, ÑдаÑÑÐ¸Ñ Ñвои ÑÐ°Ð´Ñ (ÑвободнÑÑ Ð·ÐµÐ¼Ð»Ñ) пеÑед палаÑки. Ð' Ðондоне Ñакже дозволиÑелÑно вÑÑÑеÑаÑÑ Ñайон около палаÑÐºÑ Ð² ÑаÑÑном доме, бÑÑÑ ÑÑом Ñ Ð¾Ð·Ñ ÐµÐ²Ð° пÑедлагаÑÑ Â«ÑадовÑм» поÑÑоÑлÑÑам дÑÑ Ð¸ кÑÑ Ð½Ñ, изза поÑÑоÑнно пÑиÑÑноÑÑÑ Ð¿ÑидеÑÑÑ Ð¿Ð»Ð°ÑиÑÑ 10 ÑÑнÑов Ñади ноÑÑ.
Ð'ÑиÑанÑкий клÑб кемпинга и авÑоÑÑÑизма ãîðÿ÷èå òóðû â Äóáàé (The Camping and Caravanning Order) пÑÐµÐ´Ð»Ð°Ð³Ð°ÐµÑ ÑазмеÑение во вÑеменнÑÑ ÐºÐµÐ¼Ð¿Ð¸Ð½Ð³Ð°Ñ Ñ Ð¸ÑÐ»Ñ ÑообÑазно авгÑÑÑ. СамÑе ÑдобнÑе меÑÑа ÑазмеÑÐµÐ½Ð¸Ñ Ð´Ð»Ñ Ð³Ð¾ÑÑей кемпинг в Lee Valley, в 10 минÑÑÐ°Ñ ÑеÑез ÐлимпийÑкого паÑка в «WaterWorks Creation Delay and Golf Pivot» в ÐейÑоне. Ðемпинг бÑÐ´ÐµÑ Ð¾ÑкÑÑÑ Ñ 20 иÑÐ»Ñ Ð¿Ð¾ 16 авгÑÑÑа, ÑазмеÑение 45 ÑÑнÑов поÑле ноÑÑ (минималÑнÑй ÑÑок пÑебÑÐ²Ð°Ð½Ð¸Ñ 3 днÑ), ÑÐ°Ð¹Ñ www.campingandcaravanning club.co.uk/ukcampsites/summer-2012-campsites.
ТленнÑй кемпинг бÑÐ´ÐµÑ Ð² Gravesend (20 иÑлÑ-16 авгÑÑÑа; ?30), около ÑÑанÑии Ebbsfleet Supranational Station; кемпинг Romford (24 иÑÐ»Ñ â" 20 авгÑÑÑа; ?30), в 15 минÑÑÐ°Ñ Ð½Ð° поезде ÑеÑез СÑÑаÑÑоÑда; кемпинг в паÑке Windsor Eximious Parkland (20 иÑлÑ-16 авгÑÑÑа; ?40), близ озеÑа Eton Dorney Lake, где можно занÑÑÑÑÑ ÐºÐ°Ñкингом и покаÑаÑÑÑÑ Ð´Ð»Ñ ÐºÐ°Ð½Ð¾Ðµ, ÑÐ°Ð¹Ñ www.campingandcaravanningclub.co.uk/ukcampsites/summer-2012-campsites.
Ð'о Ñезон ÐлимпиадÑ, Ñакже дозволиÑелÑно оÑÑановиÑÑÑÑ ÑпоÑÑивнÑÑ ÐºÐ»ÑÐ±Ð°Ñ Ð·Ð° Ðондоном, Ñкажем клÑб Ñегби - Blackheath Rugby Baton, Eton Manor RFC и Ñ Ð¾ÐºÐºÐµÐ¹Ð½Ñй клÑбSurbiton Hockey Club. Цена ÑазмеÑÐµÐ½Ð¸Ñ ?10 ÑÑнÑов и зза ноÑÑ Ð´Ð»Ñ Ð²Ð·ÑоÑлÑÑ Ð¸ ?5 ÑÑнÑов Ð´Ð»Ñ Ð´ÐµÑей, ÑÐ°Ð¹Ñ campingatthegames.com/book-camping-for-the-london-2012-olympic-and-paralympic-games.
РоÑкоÑнÑй кемпинг
Ð' Ðондоне ÑнедаÑÑ Áîðîâîå áàçû îòäûõà и изÑÑнÑй кемпинг â" ÑÑо кÑÑглÑÑ Ð¿Ð°Ð»Ð°Ñок (Bell Tents) в УолÑмеÑÑÐ¾Ñ (Walthamstow), в коÑоÑÑÑ Ð³Ð¾ÑÑи бÑдÑÑ Ð¿Ð¾ÑиваÑÑ Ð´Ð»Ñ Ð½Ð°Ð´ÑвнÑÑ Ð¼Ð°ÑÑаÑÐ°Ñ Ð¸ пÑоÑÑÑнÑÑ Ð¸Ð· египеÑÑкого Ñ Ð»Ð¾Ð¿ÐºÐ°, ÑаÑÑÑ Ð¿Ð¾ÑÑоÑлÑÑев кÑÑглоÑÑÑоÑнÑй, глоÑаÑÑ Ð¿Ð»Ð¾Ñадка ÑÑÐ¾Ð±Ñ Ð´ÐµÑей. ÐÑавилÑнÑй авÑобÑÑ, доÑÑавлÑÑÑий гоÑÑей в ÐлимпийÑкий ÑквеÑ, Ñакже в кемпинге бÑдÑÑ ÑазмеÑÐµÐ½Ñ Ð±Ð¾Ð»ÑÑие ÑкÑÐ°Ð½Ñ ÑÑанÑлиÑÑÑÑие ÑпоÑÑивнÑе ÑоÑÑÑÐ·Ð°Ð½Ð¸Ñ . СÑомиоÑÑÑ Ð¿ÑоживаниÑ: ?100 ÑÑнÑов за ноÑÑ Ð´Ð»Ñ Ð²Ð·ÑоÑлого, ?30 ÑÑнÑов Ñади Ñебенка Ð¾Ñ 6 пÑедваÑиÑелÑно 12 Ð»ÐµÑ Ð¸ ?5 ÑÑнÑов поÑле Ñебенка пÑежде 6 леÑ, ÑайÑ
Ð"Ñбаи пÑÐ¾Ð´Ð¾Ð»Ð¶Ð°ÐµÑ Ð¾ÑеломиÑÑ, вÑлед Ñади иÑкÑÑÑÑвеннÑм оÑÑÑовом Ñ ÑамÑм вÑÑоким оÑелем в миÑе в ÑмиÑаÑе поÑвиÑÑÑ Ð¿Ð¾Ð»ÑзаÑопленнÑй оÑелÑ. ÐомеÑа в новом оÑеле бÑдÑÑ ÑаÑÐ¿Ð¾Ð»Ð¾Ð¶ÐµÐ½Ñ Ð² моÑе, Ð´Ð»Ñ Ð³Ð»Ñбине 10 меÑÑов, ÑообÑÐ°ÐµÑ Daily Correspondence
Ð"оÑÑиниÑа «Piss of superior Discus Hostelry» Ð½Ð°Ð¿Ð¾Ð»Ð¾Ð²Ð¸Ð½Ñ ÑазмеÑÑиÑÑÑ Ð² воде, из номеÑов поÑÑоÑлÑÑÑ Ð±ÑдÑÑ Ð½Ð°Ð±Ð»ÑдаÑÑ Ð·Ð° моÑÑкой жизнÑÑ. Ð"Ð¸Ð·Ð°Ð¹Ð½ÐµÑ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸ «The waters Tons Technology» (DOT), надееÑÑ Ñ, коÑоÑÑй гоÑÑиниÑа вÑÐ·Ð¾Ð²ÐµÑ Ñ ÑÑÑиÑÑов Ð²Ð¾Ð»Ñ ÑазбиÑаÑÑ Ð¿Ð¾Ð´Ð²Ð¾Ð´Ð½Ñй ÑÐ²ÐµÑ Ð¾ÐºÐµÐ°Ð½Ð°.
СÑÑоение оÑÐµÐ»Ñ Ð±ÑÐ´ÐµÑ Ð±ÑÑÑ Ð¸Ð· двÑÑ ÑÑовней, Ñак назÑваемÑÑ Ð´Ð¸Ñков, ÑаÑполагаÑÑÐ¸Ñ ÑÑ Ð½Ð°Ð´ землей и около водой, они бÑдÑÑ ÑÐ¾ÐµÐ´Ð¸Ð½ÐµÐ½Ñ ÑÑÐµÐ¼Ñ Â«Ð½Ð¾Ð³Ð°Ð¼Ð¸Â» Ñ Ð»Ð¸ÑÑами и леÑÑниÑами. ÐÐ¾Ð´Ð²Ð¾Ð´Ð½Ð°Ñ ÑазÑÑд бÑÐ´ÐµÑ Ð´Ð»Ñ Ð³Ð»Ñбине 10 меÑÑов, в ней бÑÐ´ÐµÑ 21 номеÑа, Ð±Ð°Ñ Ð¸ дайвинг ÑенÑÑ.
СпеÑиалÑÐ½Ð°Ñ ÑлекÑÑиÑеÑÐºÐ°Ñ ÑÑение доволÑно оÑиÑÑÑ ÑлоÑÑ Ð¸ ÑаÑÐ½Ñ ÑледоваÑÑ Ð¾ÐºÐ½Ð¾Ð¼ номеÑов пеÑед водой, Ñак ÑÑо гоÑÑи ÑмогÑÑ ÑнимаÑÑ Ñвиденное. Ð' подводнÑй гоÑÑиниÑа могÑÑ ÑпÑÑÑиÑÑÑÑ Ð¸ Ñе, коÑоÑÑй опаÑаÑÑÑÑ Ð ²Ð¾Ð´Ñ, авÑоÑÑ Ð¿ÑоекÑа ÑвеÑÑÑÑ, ÑколÑко под водой бÑÐ´ÐµÑ Ð°Ð±ÑолÑÑно безопаÑно.
ÐалаÑки в ÑадÑ
Ð' Ð'ÑиÑании год вÑпÑÑÑ Ð¿Ð¾ÑвилÑÑ Ð²ÐµÐ±ÑÐ°Ð¹Ñ campinmygarden.com, Ð´Ð»Ñ ÐºÐ¾ÑоÑом ÑÑÑиÑÑÑ Ð¼Ð¾Ð³ÑÑ Ð½Ð°Ð¹Ñи меÑÑнÑÑ Ð¶Ð¸Ñелей, ÑдаÑÑÐ¸Ñ Ñвои ÑÐ°Ð´Ñ (ÑвободнÑÑ Ð·ÐµÐ¼Ð»Ñ) пеÑед палаÑки. Ð' Ðондоне Ñакже дозволиÑелÑно вÑÑÑеÑаÑÑ Ñайон около палаÑÐºÑ Ð² ÑаÑÑном доме, бÑÑÑ ÑÑом Ñ Ð¾Ð·Ñ ÐµÐ²Ð° пÑедлагаÑÑ Â«ÑадовÑм» поÑÑоÑлÑÑам дÑÑ Ð¸ кÑÑ Ð½Ñ, изза поÑÑоÑнно пÑиÑÑноÑÑÑ Ð¿ÑидеÑÑÑ Ð¿Ð»Ð°ÑиÑÑ 10 ÑÑнÑов Ñади ноÑÑ.
Ð'ÑиÑанÑкий клÑб кемпинга и авÑоÑÑÑизма ãîðÿ÷èå òóðû â Äóáàé (The Camping and Caravanning Order) пÑÐµÐ´Ð»Ð°Ð³Ð°ÐµÑ ÑазмеÑение во вÑеменнÑÑ ÐºÐµÐ¼Ð¿Ð¸Ð½Ð³Ð°Ñ Ñ Ð¸ÑÐ»Ñ ÑообÑазно авгÑÑÑ. СамÑе ÑдобнÑе меÑÑа ÑазмеÑÐµÐ½Ð¸Ñ Ð´Ð»Ñ Ð³Ð¾ÑÑей кемпинг в Lee Valley, в 10 минÑÑÐ°Ñ ÑеÑез ÐлимпийÑкого паÑка в «WaterWorks Creation Delay and Golf Pivot» в ÐейÑоне. Ðемпинг бÑÐ´ÐµÑ Ð¾ÑкÑÑÑ Ñ 20 иÑÐ»Ñ Ð¿Ð¾ 16 авгÑÑÑа, ÑазмеÑение 45 ÑÑнÑов поÑле ноÑÑ (минималÑнÑй ÑÑок пÑебÑÐ²Ð°Ð½Ð¸Ñ 3 днÑ), ÑÐ°Ð¹Ñ www.campingandcaravanning club.co.uk/ukcampsites/summer-2012-campsites.
ТленнÑй кемпинг бÑÐ´ÐµÑ Ð² Gravesend (20 иÑлÑ-16 авгÑÑÑа; ?30), около ÑÑанÑии Ebbsfleet Supranational Station; кемпинг Romford (24 иÑÐ»Ñ â" 20 авгÑÑÑа; ?30), в 15 минÑÑÐ°Ñ Ð½Ð° поезде ÑеÑез СÑÑаÑÑоÑда; кемпинг в паÑке Windsor Eximious Parkland (20 иÑлÑ-16 авгÑÑÑа; ?40), близ озеÑа Eton Dorney Lake, где можно занÑÑÑÑÑ ÐºÐ°Ñкингом и покаÑаÑÑÑÑ Ð´Ð»Ñ ÐºÐ°Ð½Ð¾Ðµ, ÑÐ°Ð¹Ñ www.campingandcaravanningclub.co.uk/ukcampsites/summer-2012-campsites.
Ð'о Ñезон ÐлимпиадÑ, Ñакже дозволиÑелÑно оÑÑановиÑÑÑÑ ÑпоÑÑивнÑÑ ÐºÐ»ÑÐ±Ð°Ñ Ð·Ð° Ðондоном, Ñкажем клÑб Ñегби - Blackheath Rugby Baton, Eton Manor RFC и Ñ Ð¾ÐºÐºÐµÐ¹Ð½Ñй клÑбSurbiton Hockey Club. Цена ÑазмеÑÐµÐ½Ð¸Ñ ?10 ÑÑнÑов и зза ноÑÑ Ð´Ð»Ñ Ð²Ð·ÑоÑлÑÑ Ð¸ ?5 ÑÑнÑов Ð´Ð»Ñ Ð´ÐµÑей, ÑÐ°Ð¹Ñ campingatthegames.com/book-camping-for-the-london-2012-olympic-and-paralympic-games.
РоÑкоÑнÑй кемпинг
Ð' Ðондоне ÑнедаÑÑ Áîðîâîå áàçû îòäûõà и изÑÑнÑй кемпинг â" ÑÑо кÑÑглÑÑ Ð¿Ð°Ð»Ð°Ñок (Bell Tents) в УолÑмеÑÑÐ¾Ñ (Walthamstow), в коÑоÑÑÑ Ð³Ð¾ÑÑи бÑдÑÑ Ð¿Ð¾ÑиваÑÑ Ð´Ð»Ñ Ð½Ð°Ð´ÑвнÑÑ Ð¼Ð°ÑÑаÑÐ°Ñ Ð¸ пÑоÑÑÑнÑÑ Ð¸Ð· египеÑÑкого Ñ Ð»Ð¾Ð¿ÐºÐ°, ÑаÑÑÑ Ð¿Ð¾ÑÑоÑлÑÑев кÑÑглоÑÑÑоÑнÑй, глоÑаÑÑ Ð¿Ð»Ð¾Ñадка ÑÑÐ¾Ð±Ñ Ð´ÐµÑей. ÐÑавилÑнÑй авÑобÑÑ, доÑÑавлÑÑÑий гоÑÑей в ÐлимпийÑкий ÑквеÑ, Ñакже в кемпинге бÑдÑÑ ÑазмеÑÐµÐ½Ñ Ð±Ð¾Ð»ÑÑие ÑкÑÐ°Ð½Ñ ÑÑанÑлиÑÑÑÑие ÑпоÑÑивнÑе ÑоÑÑÑÐ·Ð°Ð½Ð¸Ñ . СÑомиоÑÑÑ Ð¿ÑоживаниÑ: ?100 ÑÑнÑов за ноÑÑ Ð´Ð»Ñ Ð²Ð·ÑоÑлого, ?30 ÑÑнÑов Ñади Ñебенка Ð¾Ñ 6 пÑедваÑиÑелÑно 12 Ð»ÐµÑ Ð¸ ?5 ÑÑнÑов поÑле Ñебенка пÑежде 6 леÑ, ÑайÑ
Ð"Ñбаи пÑÐ¾Ð´Ð¾Ð»Ð¶Ð°ÐµÑ Ð¾ÑеломиÑÑ, вÑлед Ñади иÑкÑÑÑÑвеннÑм оÑÑÑовом Ñ ÑамÑм вÑÑоким оÑелем в миÑе в ÑмиÑаÑе поÑвиÑÑÑ Ð¿Ð¾Ð»ÑзаÑопленнÑй оÑелÑ. ÐомеÑа в новом оÑеле бÑдÑÑ ÑаÑÐ¿Ð¾Ð»Ð¾Ð¶ÐµÐ½Ñ Ð² моÑе, Ð´Ð»Ñ Ð³Ð»Ñбине 10 меÑÑов, ÑообÑÐ°ÐµÑ Daily Correspondence
Ð"оÑÑиниÑа «Piss of superior Discus Hostelry» Ð½Ð°Ð¿Ð¾Ð»Ð¾Ð²Ð¸Ð½Ñ ÑазмеÑÑиÑÑÑ Ð² воде, из номеÑов поÑÑоÑлÑÑÑ Ð±ÑдÑÑ Ð½Ð°Ð±Ð»ÑдаÑÑ Ð·Ð° моÑÑкой жизнÑÑ. Ð"Ð¸Ð·Ð°Ð¹Ð½ÐµÑ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸ «The waters Tons Technology» (DOT), надееÑÑ Ñ, коÑоÑÑй гоÑÑиниÑа вÑÐ·Ð¾Ð²ÐµÑ Ñ ÑÑÑиÑÑов Ð²Ð¾Ð»Ñ ÑазбиÑаÑÑ Ð¿Ð¾Ð´Ð²Ð¾Ð´Ð½Ñй ÑÐ²ÐµÑ Ð¾ÐºÐµÐ°Ð½Ð°.
СÑÑоение оÑÐµÐ»Ñ Ð±ÑÐ´ÐµÑ Ð±ÑÑÑ Ð¸Ð· двÑÑ ÑÑовней, Ñак назÑваемÑÑ Ð´Ð¸Ñков, ÑаÑполагаÑÑÐ¸Ñ ÑÑ Ð½Ð°Ð´ землей и около водой, они бÑдÑÑ ÑÐ¾ÐµÐ´Ð¸Ð½ÐµÐ½Ñ ÑÑÐµÐ¼Ñ Â«Ð½Ð¾Ð³Ð°Ð¼Ð¸Â» Ñ Ð»Ð¸ÑÑами и леÑÑниÑами. ÐÐ¾Ð´Ð²Ð¾Ð´Ð½Ð°Ñ ÑазÑÑд бÑÐ´ÐµÑ Ð´Ð»Ñ Ð³Ð»Ñбине 10 меÑÑов, в ней бÑÐ´ÐµÑ 21 номеÑа, Ð±Ð°Ñ Ð¸ дайвинг ÑенÑÑ.
СпеÑиалÑÐ½Ð°Ñ ÑлекÑÑиÑеÑÐºÐ°Ñ ÑÑение доволÑно оÑиÑÑÑ ÑлоÑÑ Ð¸ ÑаÑÐ½Ñ ÑледоваÑÑ Ð¾ÐºÐ½Ð¾Ð¼ номеÑов пеÑед водой, Ñак ÑÑо гоÑÑи ÑмогÑÑ ÑнимаÑÑ Ñвиденное. Ð' подводнÑй гоÑÑиниÑа могÑÑ ÑпÑÑÑиÑÑÑÑ Ð¸ Ñе, коÑоÑÑй опаÑаÑÑÑÑ Ð ²Ð¾Ð´Ñ, авÑоÑÑ Ð¿ÑоекÑа ÑвеÑÑÑÑ, ÑколÑко под водой бÑÐ´ÐµÑ Ð°Ð±ÑолÑÑно безопаÑно.
Commenting on the diagram government published today Sir Andrew Dillon, Chief Administrator of DELIGHTFULLY
SUPERIOR, the healthcare rule main part, has today published incontrovertible diagram auspices not recommending cabazitaxel (Jevtana, Sanofi) in emulsion with prednisone or prednisolone as a second queue treatment as a service to prostate cancer.
Commenting on the outline guidance published today Sir Andrew Dillon, Chief Manager of CHARMING said: We paucity to be certain that unexplored treatments provide adequate benefits to patients to justify the significant resources the NHS would shortage to make available. Although cabazitaxel has been shown to be effective in extending duration, it is also associated with a reckon of side effects [7]. The body was vexed back the nature of the health-related quality of preoccupation tidings provided next to the manufacturer.
Long ago these factors had been taken into account, the untrammelled Commission appraising this psychedelic concluded that it would not present plenty constitution extras to justify its expense, which means it would not be a get striking take advantage of of reduced NHS resources.
The sketch auspices on cabazitaxel is age with consultees, who participate in the moment to allure against it. Until POLITE issues terminal guidance, NHS bodies should make decisions locally on the funding of clear-cut treatments. This prospectus guidance does not with the help that people currently entrancing cabazitaxel will leave off receiving it. They have the way out to persevere in treatment until they and their clinicians upon it proper to stop.
Kevin Stephensâ stimulating to FD Àñòàíà òóðàãåíñòâà. Îòäûõàéòå ñ íàìè! is set to then again reinforce the Organizationâs pecuniary engagement and programme for universal expansion
The Almac Scantling is happy to publish the meeting of Kevin Stephens to the administrator fix of Finance Top dog, Almac Group, with operational from 1 January 2012.
Kevin longing get c ulpability in place of all financial aspects of Almac Guild activities globally, matchless the fiscal directing teams with a view all global operations, supporting the planned vegetation of the affair and co-ordinating financial power and reporting cranny of the Group.
After graduating from Starâs University, Belfast, with a order in Economics, Kevin accomplished as a Chartered Accountant with Ernst Young and then worked someone is concerned 14 years with Kemira NI as Fiscal Controller.
Inhibitex is a clinical-stage biopharmaceutical entourage dedicated to the phenomenon of innovative products that can treat or baffle serious infections, whose teach fuzzy is on the development of nucleotide/nucleoside analogs with a view the treatment of hepatitis C virus (HCV). Its spadework HCV asset is INX-189, an enunciated nucleotide polymerase (NS5B) inhibitor in Shape II evolvement that has exhibited vigorous antiviral enterprise, a high-priced barrier to guerillas and pa n-genotypic coverage. Nucleotides/nucleosides are emerging as an weighty classification of antivirals that may play a depreciative lines as the pillar of to be to come direct-acting antiviral-only combination approaches to HCV treatment.
The getting of Inhibitex builds on Bristol-Myers Squibb's long history of discovering, developing and delivering innovative uncharted medicines in virology and enriches our portfolio of investigational medicines in support of hepatitis C, said Lamberto Andreotti, chief administrator functionary, Bristol-Myers Squibb. There is substantial unmet medical basic in hepatitis C. This possessions represents an important investment in the long-term enlargement of the company.
This bargain proceedings puts INX-189 and the Concern's other transmissible disease assets in the hands of an systematizing that can more optimally upon them and which believes as strongly as we do in INX-189's concealed in the treatment of hardened HCV, said Russ ell Accurately, President and Chief Leader Bureaucrat of Inhibitex. Bristol-Myers Squibb's mastery in antiviral soporific growth, and its existing complementary portfolio, wishes establish that the potential of INX-189 is realized as enter in of to be to come viva voce suspension therapies in the service of millions of patients in extremity around the world.
Bristol-Myers Squibb continues to drive ãîðÿùèå òóðû èç Êàçàõñòàíà. Ïîäðîáíîñòè íà ñàéòå! advances in the cricket pitch of hepatitis C inspection and condition through internal increment and choosy partnerships, said Elliott Sigal, M.D., Ph.D., foreman imperfection president, chief methodical bureaucrat and president, RD, Bristol-Myers Squibb. The addition of Inhibitex's nucleotide polymerase inhibitor to our own propitious portfolio, which includes other direct-acting antivirals, brings additional options to broaden all-oral regimens with better drug rates, shorter duratio n of therapy and diminish toxicity than the present-day standard of care.
The bargain proceedings is expected to be dilutive to earnings looking for Bristol-Myers Squibb during 2016, with an expected import on earnings per divide up of approaching $0.04 in 2012 and approximately $0.05 in 2013.
Underneath the terms of the definitive concordat, Bristol-Myers Squibb purpose initiate a cash tender presentation to purchase all of the sensational shares of Inhibitexâs conventional traditional pro $26.00 per share. The closing of the boat make is area to everyday terms and conditions, including the tender of a party of shares that constitutes at least a majority of Inhibitexâs outstanding shares of standard lineage (on a fully diluted basis) and coming to an end or termination of the waiting time high the Hart-Scott-Rodino Antitrust Improvements Act. The understanding also provides also in behalf of the parties to any way you look at it become operative, testee to everyday conditions, a merger to be completed following the culmination of the skiff volunteer which would development in all shares not tendered in the rowing-boat propose being converted into the valid to receive $26.00 per split in cash. The merger harmony contains a provision underneath which Inhibitex has agreed not to approach any competing offers for the company. Bristol-Myers Squibb make wealth the acquisition from its existing spondulicks resources. The companies contemplate the wagon offer to bring together approximately thirty days after commencement of the dinghy offer.
Citi is serving as monetary advisor to Bristol-Myers Squibb in association contact with the purchase and Kirkland Ellis LLP is its sound advisor. Credit Suisse Securities (USA) LLC is serving as pecuniary advisor to Inhibitex in connection with the acquisition and Dechert LLP is its legal advisor.
Close to Bristol-Myers Squibb
Bristol-Myers Squibb is a epidemic biopharmaceutical group whose mission is to discover, develop and resign innovative medicines that help patients prevail over consequential diseases.
Commenting on the outline guidance published today Sir Andrew Dillon, Chief Manager of CHARMING said: We paucity to be certain that unexplored treatments provide adequate benefits to patients to justify the significant resources the NHS would shortage to make available. Although cabazitaxel has been shown to be effective in extending duration, it is also associated with a reckon of side effects [7]. The body was vexed back the nature of the health-related quality of preoccupation tidings provided next to the manufacturer.
Long ago these factors had been taken into account, the untrammelled Commission appraising this psychedelic concluded that it would not present plenty constitution extras to justify its expense, which means it would not be a get striking take advantage of of reduced NHS resources.
The sketch auspices on cabazitaxel is age with consultees, who participate in the moment to allure against it. Until POLITE issues terminal guidance, NHS bodies should make decisions locally on the funding of clear-cut treatments. This prospectus guidance does not with the help that people currently entrancing cabazitaxel will leave off receiving it. They have the way out to persevere in treatment until they and their clinicians upon it proper to stop.
Kevin Stephensâ stimulating to FD Àñòàíà òóðàãåíñòâà. Îòäûõàéòå ñ íàìè! is set to then again reinforce the Organizationâs pecuniary engagement and programme for universal expansion
The Almac Scantling is happy to publish the meeting of Kevin Stephens to the administrator fix of Finance Top dog, Almac Group, with operational from 1 January 2012.
Kevin longing get c ulpability in place of all financial aspects of Almac Guild activities globally, matchless the fiscal directing teams with a view all global operations, supporting the planned vegetation of the affair and co-ordinating financial power and reporting cranny of the Group.
After graduating from Starâs University, Belfast, with a order in Economics, Kevin accomplished as a Chartered Accountant with Ernst Young and then worked someone is concerned 14 years with Kemira NI as Fiscal Controller.
Inhibitex is a clinical-stage biopharmaceutical entourage dedicated to the phenomenon of innovative products that can treat or baffle serious infections, whose teach fuzzy is on the development of nucleotide/nucleoside analogs with a view the treatment of hepatitis C virus (HCV). Its spadework HCV asset is INX-189, an enunciated nucleotide polymerase (NS5B) inhibitor in Shape II evolvement that has exhibited vigorous antiviral enterprise, a high-priced barrier to guerillas and pa n-genotypic coverage. Nucleotides/nucleosides are emerging as an weighty classification of antivirals that may play a depreciative lines as the pillar of to be to come direct-acting antiviral-only combination approaches to HCV treatment.
The getting of Inhibitex builds on Bristol-Myers Squibb's long history of discovering, developing and delivering innovative uncharted medicines in virology and enriches our portfolio of investigational medicines in support of hepatitis C, said Lamberto Andreotti, chief administrator functionary, Bristol-Myers Squibb. There is substantial unmet medical basic in hepatitis C. This possessions represents an important investment in the long-term enlargement of the company.
This bargain proceedings puts INX-189 and the Concern's other transmissible disease assets in the hands of an systematizing that can more optimally upon them and which believes as strongly as we do in INX-189's concealed in the treatment of hardened HCV, said Russ ell Accurately, President and Chief Leader Bureaucrat of Inhibitex. Bristol-Myers Squibb's mastery in antiviral soporific growth, and its existing complementary portfolio, wishes establish that the potential of INX-189 is realized as enter in of to be to come viva voce suspension therapies in the service of millions of patients in extremity around the world.
Bristol-Myers Squibb continues to drive ãîðÿùèå òóðû èç Êàçàõñòàíà. Ïîäðîáíîñòè íà ñàéòå! advances in the cricket pitch of hepatitis C inspection and condition through internal increment and choosy partnerships, said Elliott Sigal, M.D., Ph.D., foreman imperfection president, chief methodical bureaucrat and president, RD, Bristol-Myers Squibb. The addition of Inhibitex's nucleotide polymerase inhibitor to our own propitious portfolio, which includes other direct-acting antivirals, brings additional options to broaden all-oral regimens with better drug rates, shorter duratio n of therapy and diminish toxicity than the present-day standard of care.
The bargain proceedings is expected to be dilutive to earnings looking for Bristol-Myers Squibb during 2016, with an expected import on earnings per divide up of approaching $0.04 in 2012 and approximately $0.05 in 2013.
Underneath the terms of the definitive concordat, Bristol-Myers Squibb purpose initiate a cash tender presentation to purchase all of the sensational shares of Inhibitexâs conventional traditional pro $26.00 per share. The closing of the boat make is area to everyday terms and conditions, including the tender of a party of shares that constitutes at least a majority of Inhibitexâs outstanding shares of standard lineage (on a fully diluted basis) and coming to an end or termination of the waiting time high the Hart-Scott-Rodino Antitrust Improvements Act. The understanding also provides also in behalf of the parties to any way you look at it become operative, testee to everyday conditions, a merger to be completed following the culmination of the skiff volunteer which would development in all shares not tendered in the rowing-boat propose being converted into the valid to receive $26.00 per split in cash. The merger harmony contains a provision underneath which Inhibitex has agreed not to approach any competing offers for the company. Bristol-Myers Squibb make wealth the acquisition from its existing spondulicks resources. The companies contemplate the wagon offer to bring together approximately thirty days after commencement of the dinghy offer.
Citi is serving as monetary advisor to Bristol-Myers Squibb in association contact with the purchase and Kirkland Ellis LLP is its sound advisor. Credit Suisse Securities (USA) LLC is serving as pecuniary advisor to Inhibitex in connection with the acquisition and Dechert LLP is its legal advisor.
Close to Bristol-Myers Squibb
Bristol-Myers Squibb is a epidemic biopharmaceutical group whose mission is to discover, develop and resign innovative medicines that help patients prevail over consequential diseases.
Commenting on the outline advisement published today Sir Andrew Dillon, Chief Administrator of NICE
NICE, the healthcare guidance main part, has today published concluding drawing charge not recommending cabazitaxel (Jevtana, Sanofi) in emulsion with prednisone or prednisolone as a second queue treatment for prostate cancer.
Commenting on the diagram guidance published today Sir Andrew Dillon, Chief Principal of GENTLEMANLY said: We need to be sure that unknown treatments lay down enough benefits to patients to acquit the historic resources the NHS would constraint to be placed available. Although cabazitaxel has been shown to be efficacious in extending lifetime, it is also associated with a reckon of side effects [7]. The board was vexed about the kidney of the health-related eminence of life information provided via the manufacturer.
Once these factors had been captivated into account, the independent Committee appraising this panacea concluded that it would not afford plenty salubriousness extras to justify its expense, which means it would not be a bring in effective use of reduced NHS resources.
The drawing guidance on cabazitaxel is now with consultees, who have the possibility to fascinate against it. Until NICE issues ending guidance, NHS bodies should exhort decisions locally on the funding of definitive treatments. This design guidance does not middling that people currently taking cabazitaxel liking leave off receiving it. They attired in b be committed to the selection to pursue treatment until they and their clinicians consider it proper to stop.
Kevin Stephensâ promotion to FD ãîðÿùèå òóðû èç Êàçàõñòàíà. Ïîäðîáíîñòè íà ñàéòå! is pin down to then again enhance the Groupâs monetary interpretation and programme on international growth
The Almac Scantling is thrilled to publish the assignation of Kevin Stephens to the administrator position of Money Impresario, Almac Society, with effect from 1 January 2012.
Kevin desire get responsibility ch ampioning all fiscal aspects of Almac Alliance activities globally, unequalled the financial administration teams after all international operations, supporting the planned growth of the task and co-ordinating pecuniary rule and reporting cranny of the Group.
After graduating from Leaderâs University, Belfast, with a order in Economics, Kevin experienced as a Chartered Accountant with Ernst Young and then worked someone is concerned 14 years with Kemira NI as Economic Controller.
Inhibitex is a clinical-stage biopharmaceutical associates dedicated to the expansion of innovative products that can treat or baffle dour infections, whose initial distinct is on the circumstance of nucleotide/nucleoside analogs with a view the treatment of hepatitis C virus (HCV). Its spadework HCV asset is INX-189, an word-of-mouth nucleotide polymerase (NS5B) inhibitor in Phase II maturity that has exhibited convincing antiviral energy, a maximum obstacle to defiance and pan-genotyp ic coverage. Nucleotides/nucleosides are emerging as an well-connected refinement of antivirals that may work hand in glove a serious lines as the backbone of tomorrow's direct-acting antiviral-only organization approaches to HCV treatment.
The obtaining of Inhibitex builds on Bristol-Myers Squibb's prolonged life of discovering, developing and delivering innovative restored medicines in virology and enriches our portfolio of investigational medicines object of hepatitis C, said Lamberto Andreotti, chief manager director, Bristol-Myers Squibb. There is significant unmet medical requirement in hepatitis C. This property represents an substantial investment in the long-term enlargement of the company.
This transaction puts INX-189 and the Plc's other catching sickness assets in the hands of an codification that can more optimally develop them and which believes as strongly as we do in INX-189's potential in the treatment of inveterate HCV, said Russell Accurately , President and Chief Leader Officer of Inhibitex. Bristol-Myers Squibb's mastery in antiviral dope increase, and its existing complementary portfolio, pass on certain that the potential of INX-189 is realized as part of to be to come pronounced suspension therapies for the benefit of millions of patients in need hither the world.
Bristol-Myers Squibb continues to demand ãîðÿ÷èå òóðû â Äóáàé. Îáðàùàéòåñü! advances in the field of hepatitis C analysis and condition throughout internal phenomenon and discriminatory partnerships, said Elliott Sigal, M.D., Ph.D., master evil president, chief orderly bureaucrat and president, RD, Bristol-Myers Squibb. The addendum of Inhibitex's nucleotide polymerase inhibitor to our own cheering portfolio, which includes other direct-acting antivirals, brings additional options to mature all-oral regimens with more medication rates, shorter duration of psychoanalysis and slash toxicity than the known standard of care.
The records is expected to be dilutive to earnings for Bristol-Myers Squibb through 2016, with an expected import on earnings per share of roughly $0.04 in 2012 and about $0.05 in 2013.
Under the terms of the definitive treaty, Bristol-Myers Squibb resolution initiate a lolly skiff offer to obtain all of the outstanding shares of Inhibitexâs conventional selection for $26.00 per share. The closing of the skiff offer is area to customary terms and conditions, including the tender of a total of shares that constitutes at least a majority of Inhibitexâs first-rate shares of common roots (on a fully diluted principle) and expiry or conclusion of the waiting time high the Hart-Scott-Rodino Antitrust Improvements Act. The compatibility also provides for the parties to effect, subject to customary conditions, a merging to be completed following the conclusion of the dinghy submit which would development in all shares not tendered in the rowing-bo at extend being converted into the convenient to receive $26.00 per allotment in cash. The merger unanimity contains a catering impaired which Inhibitex has agreed not to pray any competing offers for the company. Bristol-Myers Squibb bequeath financial affairs the getting from its existing exchange resources. The companies upon the wagon make available to finish almost thirty days after commencement of the tender offer.
Citi is serving as financial advisor to Bristol-Myers Squibb in connection with the purchase and Kirkland Ellis LLP is its legal advisor. Credit Suisse Securities (USA) LLC is serving as economic advisor to Inhibitex in connection with the procurement and Dechert LLP is its legal advisor.
Forth Bristol-Myers Squibb
Bristol-Myers Squibb is a extensive biopharmaceutical group whose business is to devise, enlarge on and bring into the world innovative medicines that better patients gain across serious diseases.
Commenting on the diagram guidance published today Sir Andrew Dillon, Chief Principal of GENTLEMANLY said: We need to be sure that unknown treatments lay down enough benefits to patients to acquit the historic resources the NHS would constraint to be placed available. Although cabazitaxel has been shown to be efficacious in extending lifetime, it is also associated with a reckon of side effects [7]. The board was vexed about the kidney of the health-related eminence of life information provided via the manufacturer.
Once these factors had been captivated into account, the independent Committee appraising this panacea concluded that it would not afford plenty salubriousness extras to justify its expense, which means it would not be a bring in effective use of reduced NHS resources.
The drawing guidance on cabazitaxel is now with consultees, who have the possibility to fascinate against it. Until NICE issues ending guidance, NHS bodies should exhort decisions locally on the funding of definitive treatments. This design guidance does not middling that people currently taking cabazitaxel liking leave off receiving it. They attired in b be committed to the selection to pursue treatment until they and their clinicians consider it proper to stop.
Kevin Stephensâ promotion to FD ãîðÿùèå òóðû èç Êàçàõñòàíà. Ïîäðîáíîñòè íà ñàéòå! is pin down to then again enhance the Groupâs monetary interpretation and programme on international growth
The Almac Scantling is thrilled to publish the assignation of Kevin Stephens to the administrator position of Money Impresario, Almac Society, with effect from 1 January 2012.
Kevin desire get responsibility ch ampioning all fiscal aspects of Almac Alliance activities globally, unequalled the financial administration teams after all international operations, supporting the planned growth of the task and co-ordinating pecuniary rule and reporting cranny of the Group.
After graduating from Leaderâs University, Belfast, with a order in Economics, Kevin experienced as a Chartered Accountant with Ernst Young and then worked someone is concerned 14 years with Kemira NI as Economic Controller.
Inhibitex is a clinical-stage biopharmaceutical associates dedicated to the expansion of innovative products that can treat or baffle dour infections, whose initial distinct is on the circumstance of nucleotide/nucleoside analogs with a view the treatment of hepatitis C virus (HCV). Its spadework HCV asset is INX-189, an word-of-mouth nucleotide polymerase (NS5B) inhibitor in Phase II maturity that has exhibited convincing antiviral energy, a maximum obstacle to defiance and pan-genotyp ic coverage. Nucleotides/nucleosides are emerging as an well-connected refinement of antivirals that may work hand in glove a serious lines as the backbone of tomorrow's direct-acting antiviral-only organization approaches to HCV treatment.
The obtaining of Inhibitex builds on Bristol-Myers Squibb's prolonged life of discovering, developing and delivering innovative restored medicines in virology and enriches our portfolio of investigational medicines object of hepatitis C, said Lamberto Andreotti, chief manager director, Bristol-Myers Squibb. There is significant unmet medical requirement in hepatitis C. This property represents an substantial investment in the long-term enlargement of the company.
This transaction puts INX-189 and the Plc's other catching sickness assets in the hands of an codification that can more optimally develop them and which believes as strongly as we do in INX-189's potential in the treatment of inveterate HCV, said Russell Accurately , President and Chief Leader Officer of Inhibitex. Bristol-Myers Squibb's mastery in antiviral dope increase, and its existing complementary portfolio, pass on certain that the potential of INX-189 is realized as part of to be to come pronounced suspension therapies for the benefit of millions of patients in need hither the world.
Bristol-Myers Squibb continues to demand ãîðÿ÷èå òóðû â Äóáàé. Îáðàùàéòåñü! advances in the field of hepatitis C analysis and condition throughout internal phenomenon and discriminatory partnerships, said Elliott Sigal, M.D., Ph.D., master evil president, chief orderly bureaucrat and president, RD, Bristol-Myers Squibb. The addendum of Inhibitex's nucleotide polymerase inhibitor to our own cheering portfolio, which includes other direct-acting antivirals, brings additional options to mature all-oral regimens with more medication rates, shorter duration of psychoanalysis and slash toxicity than the known standard of care.
The records is expected to be dilutive to earnings for Bristol-Myers Squibb through 2016, with an expected import on earnings per share of roughly $0.04 in 2012 and about $0.05 in 2013.
Under the terms of the definitive treaty, Bristol-Myers Squibb resolution initiate a lolly skiff offer to obtain all of the outstanding shares of Inhibitexâs conventional selection for $26.00 per share. The closing of the skiff offer is area to customary terms and conditions, including the tender of a total of shares that constitutes at least a majority of Inhibitexâs first-rate shares of common roots (on a fully diluted principle) and expiry or conclusion of the waiting time high the Hart-Scott-Rodino Antitrust Improvements Act. The compatibility also provides for the parties to effect, subject to customary conditions, a merging to be completed following the conclusion of the dinghy submit which would development in all shares not tendered in the rowing-bo at extend being converted into the convenient to receive $26.00 per allotment in cash. The merger unanimity contains a catering impaired which Inhibitex has agreed not to pray any competing offers for the company. Bristol-Myers Squibb bequeath financial affairs the getting from its existing exchange resources. The companies upon the wagon make available to finish almost thirty days after commencement of the tender offer.
Citi is serving as financial advisor to Bristol-Myers Squibb in connection with the purchase and Kirkland Ellis LLP is its legal advisor. Credit Suisse Securities (USA) LLC is serving as economic advisor to Inhibitex in connection with the procurement and Dechert LLP is its legal advisor.
Forth Bristol-Myers Squibb
Bristol-Myers Squibb is a extensive biopharmaceutical group whose business is to devise, enlarge on and bring into the world innovative medicines that better patients gain across serious diseases.
Подписаться на:
Сообщения (Atom)